{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:46:47Z","timestamp":1786981607858,"version":"build-2736575974"},"reference-count":329,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11095-026-04095-3","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:14:10Z","timestamp":1776806050000},"page":"1935-1977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations"],"prefix":"10.1007","volume":"43","author":[{"given":"Julie R.","family":"Youssef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M.","family":"Elgammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina M.","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha F.","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7841-7218","authenticated-orcid":false,"given":"George","family":"Bebawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"4095_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31:1154\u201362. https:\/\/doi.org\/10.1038\/s41591-025-03502-3.","journal-title":"Nat Med"},{"key":"4095_CR2","unstructured":"Breast cancer cases and deaths are projected to rise globally [Internet]. [cited 2025 Dec 25]. https:\/\/www.iarc.who.int\/news-events\/breast-cancer-cases-and-deaths-are-projected-to-rise-globally. Accessed 25 Dec 2025"},{"key":"4095_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. npj Breast Cancer Nature Publishing Group. 2022;8:95. https:\/\/doi.org\/10.1038\/s41523-022-00468-0.","journal-title":"npj Breast Cancer. Nature Publishing Group"},{"key":"4095_CR4","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2025.5758","volume":"66","author":"E-S Kim","year":"2025","unstructured":"Kim E-S. Molecular targets and therapies associated with poor prognosis of triple-negative breast cancer (Review). Int J Oncol. 2025;66:52. https:\/\/doi.org\/10.3892\/ijo.2025.5758.","journal-title":"Int J Oncol"},{"key":"4095_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108108","volume":"236","author":"J Yu","year":"2022","unstructured":"Yu J, Mu Q, Fung M, Xu X, Zhu L, Ho RJ. Challenges and opportunities in metastatic breast cancer treatments: nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response. Pharmacol Ther. 2022;236:108108. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108108.","journal-title":"Pharmacol Ther"},{"key":"4095_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071796","volume":"15","author":"O Obidiro","year":"2023","unstructured":"Obidiro O, Battogtokh G, Akala EO. Triple negative breast cancer treatment options and limitations: future outlook. Pharmaceutics. 2023;15:1796. https:\/\/doi.org\/10.3390\/pharmaceutics15071796.","journal-title":"Pharmaceutics"},{"key":"4095_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082042","volume":"15","author":"HB Koh","year":"2023","unstructured":"Koh HB, Kim HJ, Kang S-W, Yoo T-H. Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. 2023;15:2042. https:\/\/doi.org\/10.3390\/pharmaceutics15082042.","journal-title":"Pharmaceutics"},{"key":"4095_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtadv.2025.100623","volume":"28","author":"E Dikici","year":"2025","unstructured":"Dikici E, \u00d6nal Acet B, G\u00fcl D, Kummer N, Stauber RH, Odaba\u015f\u0131 M, et al. Bringing exosomes into the game: Current situation, opportunities, limitations and future perspectives. Materials Today Advances. 2025;28:100623. https:\/\/doi.org\/10.1016\/j.mtadv.2025.100623.","journal-title":"Materials Today Advances"},{"key":"4095_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02215-4","volume":"24","author":"J Li","year":"2025","unstructured":"Li J, Wang J, Chen Z. Emerging role of exosomes in cancer therapy: progress and challenges. Mol Cancer. 2025;24:13. https:\/\/doi.org\/10.1186\/s12943-024-02215-4.","journal-title":"Mol Cancer"},{"key":"4095_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101336","author":"DR Serrano","year":"2025","unstructured":"Serrano DR, Juste F, Anaya BJ, Ramirez BI, S\u00e1nchez-Guirales SA, Quispillo JM, et al. Exosome-based drug delivery: a next-generation platform for cancer, infection, neurological and immunological diseases, gene therapy and regenerative medicine. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17101336.","journal-title":"Pharmaceutics"},{"key":"4095_CR11","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1021\/acsnano.3c09491","volume":"18","author":"A Bahreyni","year":"2024","unstructured":"Bahreyni A, Mohamud Y, Ashraf Nouhegar S, Zhang J, Luo H. Synergistic viro-chemoimmunotherapy in breast cancer enabled by bioengineered immunostimulatory exosomes and dual-targeted Coxsackievirus B3. ACS Nano. 2024;18:4241\u201355. https:\/\/doi.org\/10.1021\/acsnano.3c09491.","journal-title":"ACS Nano"},{"key":"4095_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02298-7","volume":"22","author":"Q Yang","year":"2024","unstructured":"Yang Q, Li S, Ou H, Zhang Y, Zhu G, Li S, et al. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application. J Nanobiotechnol. 2024;22:41. https:\/\/doi.org\/10.1186\/s12951-024-02298-7.","journal-title":"J Nanobiotechnol"},{"key":"4095_CR13","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.ymthe.2018.09.015","volume":"26","author":"RA Haraszti","year":"2018","unstructured":"Haraszti RA, Miller R, Stoppato M, Sere YY, Coles A, Didiot M-C, et al. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol Ther. 2018;26:2838\u201347. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.015.","journal-title":"Mol Ther"},{"key":"4095_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4048\/jbc.2024.0262","volume":"28","author":"WY Sun","year":"2025","unstructured":"Sun WY, Lee D-S, Park JH, Kim O-H, Choi HJ, Kim S-J. Utilizing miR-34a-loaded HER2-targeting exosomes to improve breast cancer treatment: insights from an animal model. J Breast Cancer. 2025;28:139\u201357. https:\/\/doi.org\/10.4048\/jbc.2024.0262.","journal-title":"J Breast Cancer"},{"key":"4095_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12010-018-2813-4","volume":"187","author":"SK Limoni","year":"2019","unstructured":"Limoni SK, Moghadam MF, Moazzeni SM, Gomari H, Salimi F. Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells. Appl Biochem Biotechnol. 2019;187:352\u201364. https:\/\/doi.org\/10.1007\/s12010-018-2813-4.","journal-title":"Appl Biochem Biotechnol"},{"key":"4095_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.966981","volume":"12","author":"X Yi","year":"2022","unstructured":"Yi X, Chen J, Huang D, Feng S, Yang T, Li Z, et al. Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis. Front Oncol. 2022;12:966981. https:\/\/doi.org\/10.3389\/fonc.2022.966981.","journal-title":"Front Oncol"},{"key":"4095_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00959-4","volume":"20","author":"J Rezaie","year":"2022","unstructured":"Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal. 2022;20:145. https:\/\/doi.org\/10.1186\/s12964-022-00959-4.","journal-title":"Cell Commun Signal"},{"key":"4095_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13287-025-04133-8","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang C, Feng Y, Rong X, Yan J, Lv B, Jiang H, et al. Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review. Stem Cell Res Ther. 2025;16:18. https:\/\/doi.org\/10.1186\/s13287-025-04133-8.","journal-title":"Stem Cell Res Ther"},{"key":"4095_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-47","author":"TS Chen","year":"2011","unstructured":"Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo ABH, et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med. 2011. https:\/\/doi.org\/10.1186\/1479-5876-9-47.","journal-title":"J Transl Med"},{"key":"4095_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082070","volume":"15","author":"S Luo","year":"2023","unstructured":"Luo S, Chen J, Xu F, Chen H, Li Y, Li W. Dendritic cell-derived exosomes in cancer immunotherapy. Pharmaceutics. 2023;15:2070. https:\/\/doi.org\/10.3390\/pharmaceutics15082070.","journal-title":"Pharmaceutics"},{"key":"4095_CR21","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5484","volume":"55","author":"X Chen","year":"2025","unstructured":"Chen X, Tian B, Wang Y, Zheng J, Kang X. Potential and challenges of utilizing exosomes in osteoarthritis therapy (Review). Int J Mol Med. 2025;55:43. https:\/\/doi.org\/10.3892\/ijmm.2025.5484.","journal-title":"Int J Mol Med"},{"key":"4095_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells13231956","author":"S Yadav","year":"2024","unstructured":"Yadav S, Maity P, Kapat K, Yadav S, Maity P, Kapat K. The opportunities and challenges of mesenchymal stem cells-derived exosomes in theranostics and regenerative medicine. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13231956.","journal-title":"Cells"},{"key":"4095_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.908830","author":"H Cai","year":"2022","unstructured":"Cai H, Huang L-Y, Hong R, Song J-X, Guo X-J, Zhou W, et al. Momordica charantia exosome-like nanoparticles exert neuroprotective effects against ischemic brain injury via inhibiting matrix metalloproteinase 9 and activating the AKT\/GSK3\u03b2 signaling pathway. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.908830.","journal-title":"Front Pharmacol"},{"key":"4095_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202101741","author":"HP Bei","year":"2021","unstructured":"Bei HP, Hung PM, Yeung HL, Wang S, Zhao X. Bone\u2010a\u2010petite: engineering exosomes towards bone, osteochondral, and cartilage repair. Small. 2021. https:\/\/doi.org\/10.1002\/smll.202101741.","journal-title":"Small"},{"key":"4095_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020147","author":"Y Chen","year":"2025","unstructured":"Chen Y, Qi W, Wang Z, Niu F, Chen Y, Qi W, et al. Exosome source matters: a comprehensive review from the perspective of diverse cellular origins. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17020147.","journal-title":"Pharmaceutics"},{"key":"4095_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212092","volume":"25","author":"A Sha","year":"2024","unstructured":"Sha A, Luo Y, Xiao W, He J, Chen X, Xiong Z, et al. Plant-derived exosome-like nanoparticles: a comprehensive overview of their composition, biogenesis, isolation, and biological applications. Int J Mol Sci. 2024;25:12092. https:\/\/doi.org\/10.3390\/ijms252212092.","journal-title":"Int J Mol Sci"},{"key":"4095_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29245835","volume":"29","author":"M Jab\u0142o\u0144ska","year":"2024","unstructured":"Jab\u0142o\u0144ska M, Sawicki T, \u017bulewska J, Staniewska K, \u0141obacz A, Przyby\u0142owicz KE. The role of bovine milk-derived exosomes in human health and disease. Molecules. 2024;29:5835. https:\/\/doi.org\/10.3390\/molecules29245835.","journal-title":"Molecules"},{"key":"4095_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","volume":"23","author":"M Gimona","year":"2021","unstructured":"Gimona M, Brizzi MF, Choo ABH, Dominici M, Davidson SM, Grillari J, et al. Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy. 2021;23:373\u201380. https:\/\/doi.org\/10.1016\/j.jcyt.2021.01.001.","journal-title":"Cytotherapy"},{"key":"4095_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav8521","volume":"11","author":"OPB Wiklander","year":"2019","unstructured":"Wiklander OPB, Brennan M\u00c1, L\u00f6tvall J, Breakefield XO, El Andaloussi S. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. 2019;11:eaav8521. https:\/\/doi.org\/10.1126\/scitranslmed.aav8521.","journal-title":"Sci Transl Med"},{"key":"4095_CR30","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.30087","volume":"4","author":"T Lener","year":"2015","unstructured":"Lener T, Gimona M, Aigner L, B\u00f6rger V, Buzas E, Camussi G, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087. https:\/\/doi.org\/10.3402\/jev.v4.30087.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"key":"4095_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5516078","volume":"2021","author":"M Sheykhhasan","year":"2021","unstructured":"Sheykhhasan M, Kalhor N, Sheikholeslami A, Dolati M, Amini E, Fazaeli H. Exosomes of mesenchymal stem cells as a proper vehicle for transfecting miR-145 into the breast cancer cell line and its effect on metastasis. Biomed Res Int. 2021;2021:5516078. https:\/\/doi.org\/10.1155\/2021\/5516078.","journal-title":"Biomed Res Int"},{"key":"4095_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03501-3","volume":"24","author":"M Hosseini","year":"2024","unstructured":"Hosseini M, Ezzeddini R, Hashemi SM, Soudi S, Salek Farrokhi A. Enhanced anti-tumor efficacy of S3I-201 in breast cancer mouse model through Wharton jelly- exosome. Cancer Cell Int. 2024;24:318. https:\/\/doi.org\/10.1186\/s12935-024-03501-3.","journal-title":"Cancer Cell Int"},{"key":"4095_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04045-1","volume":"23","author":"R Ramezani","year":"2023","unstructured":"Ramezani R, Mohammadian M, Hosseini ES, Zare M. The effect of bovine milk lactoferrin-loaded exosomes (exoLF) on human MDA-MB-231 breast cancer cell line. BMC Complement Med Ther. 2023;23:228. https:\/\/doi.org\/10.1186\/s12906-023-04045-1.","journal-title":"BMC Complement Med Ther"},{"key":"4095_CR35","doi-asserted-by":"publisher","unstructured":"Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35:2383\u201390. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.11.083.","DOI":"10.1016\/j.biomaterials.2013.11.083"},{"key":"4095_CR36","doi-asserted-by":"publisher","unstructured":"Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F, et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nature Communications [Internet]. Springer Science and Business Media LLC; 2019;10. https:\/\/doi.org\/10.1038\/s41467-019-11718-4","DOI":"10.1038\/s41467-019-11718-4"},{"key":"4095_CR37","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine. 2020;15:6917\u201334. https:\/\/doi.org\/10.2147\/IJN.S264498.","journal-title":"Int J Nanomedicine"},{"key":"4095_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1697028","volume":"9","author":"Y Tian","year":"2019","unstructured":"Tian Y, Gong M, Hu Y, Liu H, Zhang W, Zhang M, et al. Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J Extracell Vesicles. 2019;9:1697028. https:\/\/doi.org\/10.1080\/20013078.2019.1697028.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR39","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v5.30829","volume":"5","author":"K Iwai","year":"2016","unstructured":"Iwai K, Minamisawa T, Suga K, Yajima Y, Shiba K. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J Extracell Vesicles. 2016;5:10.3402\/jev.v5.30829. https:\/\/doi.org\/10.3402\/jev.v5.30829.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR40","doi-asserted-by":"publisher","unstructured":"Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335. https:\/\/doi.org\/10.1038\/nature15756.","DOI":"10.1038\/nature15756"},{"key":"4095_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107263","volume":"112","author":"YW Liew","year":"2025","unstructured":"Liew YW, Goh JX, Lim JS, Hamzah S, Daniel Looi QH, Lim MN, et al. Optimizing purification techniques and evaluating cytotoxicity of NK-92-derived small extracellular vesicles for sEVs-Liposome hybrid development in drug delivery. Journal of Drug Delivery Science and Technology. 2025;112:107263. https:\/\/doi.org\/10.1016\/j.jddst.2025.107263.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"4095_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells7120273","volume":"7","author":"S Busatto","year":"2018","unstructured":"Busatto S, Vilanilam G, Ticer T, Lin W-L, Dickson DW, Shapiro S, et al. Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid. Cells. 2018;7:273. https:\/\/doi.org\/10.3390\/cells7120273.","journal-title":"Cells"},{"key":"4095_CR43","doi-asserted-by":"publisher","first-page":"12266","DOI":"10.1002\/jev2.12266","volume":"11","author":"KS Visan","year":"2022","unstructured":"Visan KS, Lobb RJ, Ham S, Lima LG, Palma C, Edna CPZ, et al. Comparative analysis of tangential flow filtration and ultracentrifugation, both combined with subsequent size exclusion chromatography, for the isolation of small extracellular vesicles. J Extracell Vesicles. 2022;11:12266. https:\/\/doi.org\/10.1002\/jev2.12266.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2020.461773","volume":"1636","author":"T Liangsupree","year":"2021","unstructured":"Liangsupree T, Multia E, Riekkola M-L. Modern isolation and separation techniques for extracellular vesicles. J Chromatogr A. 2021;1636:461773. https:\/\/doi.org\/10.1016\/j.chroma.2020.461773.","journal-title":"J Chromatogr A"},{"key":"4095_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04440-0","volume":"16","author":"SZA Malik","year":"2025","unstructured":"Malik SZA, Muhilan Y, Nordin F, Ng MH, Law JX, Imran SAM, et al. Stem cell derived exosome trilogy: an epic comparison of human MSCs, ESCs and iPSCs. Stem Cell Res Ther. 2025;16:318. https:\/\/doi.org\/10.1186\/s13287-025-04440-0.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4095_CR46","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1038\/s41598-018-22142-x","volume":"8","author":"AH Gheinani","year":"2018","unstructured":"Gheinani AH, V\u00f6geli M, Baumgartner U, Vassella E, Draeger A, Burkhard FC, et al. Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery. Sci Rep. 2018;8:3945. https:\/\/doi.org\/10.1038\/s41598-018-22142-x.","journal-title":"Sci Rep"},{"key":"4095_CR47","doi-asserted-by":"publisher","unstructured":"Baranyai T, Herczeg K, On\u00f3di Z, Voszka I, M\u00f3dos K, Marton N, et al. Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One. 2015;10:e0145686. https:\/\/doi.org\/10.1371\/journal.pone.0145686.","DOI":"10.1371\/journal.pone.0145686"},{"key":"4095_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143350","volume":"14","author":"MI Mitchell","year":"2022","unstructured":"Mitchell MI, Ma J, Carter CL, Loudig O. Circulating exosome cargoes contain functionally diverse cancer biomarkers: from biogenesis and function to purification and potential translational utility. Cancers (Basel). 2022;14:3350. https:\/\/doi.org\/10.3390\/cancers14143350.","journal-title":"Cancers (Basel)"},{"key":"4095_CR49","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1016\/j.bioactmat.2021.03.015","volume":"6","author":"K Abhange","year":"2021","unstructured":"Abhange K, Makler A, Wen Y, Ramnauth N, Mao W, Asghar W, et al. Small extracellular vesicles in cancer. Bioact Mater. 2021;6:3705\u201343. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.03.015.","journal-title":"Bioact Mater"},{"key":"4095_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175050","volume":"12","author":"S Fang","year":"2017","unstructured":"Fang S, Tian H, Li X, Jin D, Li X, Kong J, et al. Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS One. 2017;12:e0175050. https:\/\/doi.org\/10.1371\/journal.pone.0175050.","journal-title":"PLoS One"},{"key":"4095_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5806\/AST.2025.38.2.42","volume":"38","author":"MA Gab-Allah","year":"2025","unstructured":"Gab-Allah MA, Jeongkwon K. Polyethylene glycol (PEG)-based precipitation for exosome enrichment: a review on recent developments, current challenges, and future perspectives. Anal Sci Technol. 2025;38:42\u201364. https:\/\/doi.org\/10.5806\/AST.2025.38.2.42.","journal-title":"Anal Sci Technol"},{"key":"4095_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70584-z","volume":"10","author":"HH Jung","year":"2020","unstructured":"Jung HH, Kim J-Y, Lim JE, Im Y-H. Cytokine profiling in serum-derived exosomes isolated by different methods. Sci Rep. 2020;10:14069. https:\/\/doi.org\/10.1038\/s41598-020-70584-z.","journal-title":"Sci Rep"},{"key":"4095_CR53","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.trac.2019.06.037","volume":"118","author":"W Su","year":"2019","unstructured":"Su W, Li H, Chen W, Qin J. Microfluidic strategies for label-free exosomes isolation and analysis. TrAC Trends Anal Chem. 2019;118:686\u201398. https:\/\/doi.org\/10.1016\/j.trac.2019.06.037.","journal-title":"TrAC Trends Anal Chem"},{"key":"4095_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1100892","volume":"10","author":"J Gao","year":"2023","unstructured":"Gao J, Li A, Hu J, Feng L, Liu L, Shen Z. Recent developments in isolating methods for exosomes. Front Bioeng Biotechnol. 2023;10:1100892. https:\/\/doi.org\/10.3389\/fbioe.2022.1100892.","journal-title":"Front Bioeng Biotechnol"},{"key":"4095_CR55","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1073\/pnas.1709210114","volume":"114","author":"M Wu","year":"2017","unstructured":"Wu M, Ouyang Y, Wang Z, Zhang R, Huang P-H, Chen C, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci USA. 2017;114:10584\u20139. https:\/\/doi.org\/10.1073\/pnas.1709210114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4095_CR56","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/abde70","volume":"16","author":"M-CN Le","year":"2021","unstructured":"Le M-CN, Fan ZH. Exosome isolation using nanostructures and microfluidic devices. Biomed Mater. 2021;16:022005. https:\/\/doi.org\/10.1088\/1748-605X\/abde70.","journal-title":"Biomed Mater"},{"key":"4095_CR57","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1007\/s12010-022-04272-1","volume":"195","author":"H Fang","year":"2023","unstructured":"Fang H, Liu M, Jiang W. Nickel-doped microfluidic chip for rapid and efficient immunomagnetic separation and detection of breast cancer cell-derived exosomes. Appl Biochem Biotechnol. 2023;195:3109\u201321. https:\/\/doi.org\/10.1007\/s12010-022-04272-1.","journal-title":"Appl Biochem Biotechnol"},{"key":"4095_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2021.113495","volume":"192","author":"H Gwak","year":"2021","unstructured":"Gwak H, Park S, Kim J, Lee JD, Kim I-S, Kim S-I, et al. Microfluidic chip for rapid and selective isolation of tumor-derived extracellular vesicles for early diagnosis and metastatic risk evaluation of breast cancer. Biosens Bioelectron. 2021;192:113495. https:\/\/doi.org\/10.1016\/j.bios.2021.113495.","journal-title":"Biosens Bioelectron"},{"key":"4095_CR59","doi-asserted-by":"publisher","DOI":"10.1063\/1.5110973","volume":"13","author":"W Chen","year":"2019","unstructured":"Chen W, Li H, Su W, Qin J. Microfluidic device for on-chip isolation and detection of circulating exosomes in blood of breast cancer patients. Biomicrofluidics. 2019;13:054113. https:\/\/doi.org\/10.1063\/1.5110973.","journal-title":"Biomicrofluidics"},{"key":"4095_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmi.2025.100007","volume":"1","author":"X Chen","year":"2025","unstructured":"Chen X, Liu X, Zhang C, Xia H, Qin X, Guo Y, et al. Isolation and detection of exosomes on microfluidic chips. Biomedical Instrumentation. 2025;1:100007. https:\/\/doi.org\/10.1016\/j.bmi.2025.100007.","journal-title":"Biomedical Instrumentation"},{"key":"4095_CR61","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1039\/D1AN00024A","volume":"146","author":"K Singh","year":"2021","unstructured":"Singh K, Nalabotala R, M. Koo K, Bose S, Nayak R, A. Shiddiky MJ, et al. Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges. Analyst. 2021;146:3731\u201349. https:\/\/doi.org\/10.1039\/D1AN00024A.","journal-title":"Analyst"},{"key":"4095_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202301624","volume":"8","author":"G Kim","year":"2024","unstructured":"Kim G, Seo M, Xu J, Park J, Gim S, Chun H. Large-area silicon nitride nanosieve for enhanced diffusion-based exosome isolation. Small Methods. 2024;8:e2301624. https:\/\/doi.org\/10.1002\/smtd.202301624.","journal-title":"Small Methods"},{"key":"4095_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2024.136233","volume":"418","author":"G Kim","year":"2024","unstructured":"Kim G, Kim K-H, Seo M, Kim T, Chun H. High-throughput exosome isolation based on bidirectional flow control through nanoporous membrane. Sens Actuators B Chem. 2024;418:136233. https:\/\/doi.org\/10.1016\/j.snb.2024.136233.","journal-title":"Sens Actuators B Chem"},{"key":"4095_CR64","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/bios11090347","volume":"11","author":"G Kim","year":"2021","unstructured":"Kim G, Park MC, Jang S, Han D, Kim H, Kim W, et al. Diffusion-Based Separation of Extracellular Vesicles by Nanoporous Membrane Chip. Biosensors (Basel). 2021;11:347. https:\/\/doi.org\/10.3390\/bios11090347.","journal-title":"Biosensors (Basel)"},{"key":"4095_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/mi15020249","volume":"15","author":"SB Han","year":"2024","unstructured":"Han SB, Lee SS, Multidisciplinary Digital Publishing Institute. Simultaneous detection of exosomal microRNAs isolated from cancer cells using surface acoustic wave sensor array with high sensitivity and reproducibility. Micromachines. 2024;15:249. https:\/\/doi.org\/10.3390\/mi15020249.","journal-title":"Micromachines"},{"key":"4095_CR66","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1021\/acs.analchem.2c04106","volume":"95","author":"JM Nikoloff","year":"2023","unstructured":"Nikoloff JM, Saucedo-Espinosa MA, Dittrich PS, American Chemical Society. Microfluidic platform for profiling of extracellular vesicles from single breast cancer cells. Anal Chem. 2023;95:1933\u20139. https:\/\/doi.org\/10.1021\/acs.analchem.2c04106.","journal-title":"Anal Chem"},{"key":"4095_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/mi12121534","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Qu Y, Wang H, Multidisciplinary Digital Publishing Institute. Immuno-acoustic sorting of disease-specific extracellular vesicles by acoustophoretic force. Micromachines. 2021;12:1534. https:\/\/doi.org\/10.3390\/mi12121534.","journal-title":"Micromachines"},{"key":"4095_CR68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12033-021-00300-3","volume":"63","author":"TK Kurian","year":"2021","unstructured":"Kurian TK, Banik S, Gopal D, Chakrabarti S, Mazumder N. Elucidating methods for isolation and quantification of exosomes: a review. Mol Biotechnol. 2021;63:249\u201366. https:\/\/doi.org\/10.1007\/s12033-021-00300-3.","journal-title":"Mol Biotechnol"},{"key":"4095_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.152067","volume":"491","author":"M Lan","year":"2024","unstructured":"Lan M, Yang F. Applications of dielectrophoresis in microfluidic-based exosome separation and detection. Chem Eng J. 2024;491:152067. https:\/\/doi.org\/10.1016\/j.cej.2024.152067.","journal-title":"Chem Eng J"},{"key":"4095_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2023.135207","volume":"404","author":"S Kim","year":"2024","unstructured":"Kim S, Song J, Roh SM, Kim HJ, Kim H, Lee S, et al. Efficient exosome separation utilizing dielectrophoretic force in conductive spiral microfluidic chips and validation via a reduced graphene oxide (rGO)-based biosensor. Sens Actuators, B Chem. 2024;404:135207. https:\/\/doi.org\/10.1016\/j.snb.2023.135207.","journal-title":"Sens Actuators, B Chem"},{"key":"4095_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116382","volume":"259","author":"M Lan","year":"2024","unstructured":"Lan M, Ren Z, Cheng C, Li G, Yang F. Small extracellular vesicles detection using dielectrophoresis-based microfluidic chip for diagnosis of breast cancer. Biosens Bioelectron. 2024;259:116382. https:\/\/doi.org\/10.1016\/j.bios.2024.116382.","journal-title":"Biosens Bioelectron"},{"key":"4095_CR72","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der Pol E, B\u00f6ing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64:676\u2013705. https:\/\/doi.org\/10.1124\/pr.112.005983.","journal-title":"Pharmacol Rev"},{"key":"4095_CR73","doi-asserted-by":"publisher","unstructured":"I.\u00a0Ramirez M, G.\u00a0Amorim M, Gadelha C, Milic I, A.\u00a0Welsh J, M.\u00a0Freitas V, et al. Technical challenges of working with extracellular vesicles. Nanoscale. Royal Society of Chemistry; 2018;10:881\u2013906. https:\/\/doi.org\/10.1039\/C7NR08360B.","DOI":"10.1039\/C7NR08360B"},{"key":"4095_CR74","doi-asserted-by":"publisher","first-page":"32945","DOI":"10.3402\/jev.v5.32945","volume":"5","author":"C Gardiner","year":"2016","unstructured":"Gardiner C, Di Vizio D, Sahoo S, Th\u00e9ry C, Witwer KW, Wauben M, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5:32945. https:\/\/doi.org\/10.3402\/jev.v5.32945.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR75","doi-asserted-by":"publisher","first-page":"31655","DOI":"10.3402\/jev.v5.31655","volume":"5","author":"Z Andreu","year":"2016","unstructured":"Andreu Z, Rivas E, Sanguino-Pascual A, Lamana A, Marazuela M, Gonz\u00e1lez-Alvaro I, et al. Comparative analysis of EV isolation procedures for miRNAs detection in serum samples. J Extracell Vesicles. 2016;5:31655. https:\/\/doi.org\/10.3402\/jev.v5.31655.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR76","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1039\/C2LC41006K","volume":"12","author":"RT Davies","year":"2012","unstructured":"Davies RT, Kim J, Jang SC, Choi E-J, Gho YS, Park J, et al. Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip. 2012;12:5202\u201310. https:\/\/doi.org\/10.1039\/C2LC41006K.","journal-title":"Lab Chip"},{"key":"4095_CR77","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.nano.2015.01.003","volume":"11","author":"JZ Nordin","year":"2015","unstructured":"Nordin JZ, Lee Y, Vader P, M\u00e4ger I, Johansson HJ, Heusermann W, et al. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine. 2015;11:879\u201383. https:\/\/doi.org\/10.1016\/j.nano.2015.01.003.","journal-title":"Nanomedicine"},{"key":"4095_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2017.00039","volume":"5","author":"CJE Wahlund","year":"2017","unstructured":"Wahlund CJE, Eklund A, Grunewald J, Gabrielsson S. Pulmonary extracellular vesicles as mediators of local and systemic inflammation. Front Cell Dev Biol. 2017;5:39. https:\/\/doi.org\/10.3389\/fcell.2017.00039.","journal-title":"Front Cell Dev Biol"},{"key":"4095_CR79","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/pmic.201300282","volume":"13","author":"H Kalra","year":"2013","unstructured":"Kalra H, Adda CG, Liem M, Ang C-S, Mechler A, Simpson RJ, et al. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics. 2013;13:3354\u201364. https:\/\/doi.org\/10.1002\/pmic.201300282.","journal-title":"Proteomics"},{"key":"4095_CR80","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373\u201383. https:\/\/doi.org\/10.1083\/jcb.201211138.","journal-title":"J Cell Biol"},{"key":"4095_CR81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ymeth.2012.01.002","volume":"56","author":"BJ Tauro","year":"2012","unstructured":"Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012;56:293\u2013304. https:\/\/doi.org\/10.1016\/j.ymeth.2012.01.002.","journal-title":"Methods"},{"key":"4095_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-017-0856-9","volume":"17","author":"M Popovic","year":"2018","unstructured":"Popovic M, Mazzega E, Toffoletto B, de Marco A. Isolation of anti-extra-cellular vesicle single-domain antibodies by direct panning on vesicle-enriched fractions. Microb Cell Fact. 2018;17:6. https:\/\/doi.org\/10.1186\/s12934-017-0856-9.","journal-title":"Microb Cell Fact"},{"key":"4095_CR83","doi-asserted-by":"publisher","first-page":"19598","DOI":"10.1039\/D1RA01576A","volume":"11","author":"R Bano","year":"2021","unstructured":"Bano R, Ahmad F, Mohsin M, Royal Society of Chemistry. A perspective on the isolation and characterization of extracellular vesicles from different biofluids. RSC Advances. 2021;11:19598\u2013615. https:\/\/doi.org\/10.1039\/D1RA01576A.","journal-title":"RSC Advances"},{"key":"4095_CR84","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/intimm\/dxh267","volume":"17","author":"M-P Caby","year":"2005","unstructured":"Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005;17:879\u201387. https:\/\/doi.org\/10.1093\/intimm\/dxh267.","journal-title":"Int Immunol"},{"key":"4095_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/srep10266","volume":"5","author":"L Balaj","year":"2015","unstructured":"Balaj L, Atai NA, Chen W, Mu D, Tannous BA, Breakefield XO, et al. Heparin affinity purification of extracellular vesicles. Sci Rep. 2015;5:10266. https:\/\/doi.org\/10.1038\/srep10266.","journal-title":"Sci Rep"},{"key":"4095_CR86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ab.2012.09.008","volume":"431","author":"CE Yoo","year":"2012","unstructured":"Yoo CE, Kim G, Kim M, Park D, Kang HJ, Lee M, et al. A direct extraction method for microRNAs from exosomes captured by immunoaffinity beads. Anal Biochem. 2012;431:96\u20138. https:\/\/doi.org\/10.1016\/j.ab.2012.09.008.","journal-title":"Anal Biochem"},{"key":"4095_CR87","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1021\/pr8004887","volume":"7","author":"J Conde-Vancells","year":"2008","unstructured":"Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle M, et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res. 2008;7:5157\u201366. https:\/\/doi.org\/10.1021\/pr8004887.","journal-title":"J Proteome Res"},{"key":"4095_CR88","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.26659","volume":"4","author":"KR Jakobsen","year":"2015","unstructured":"Jakobsen KR, Paulsen BS, B\u00e6k R, Varming K, Sorensen BS, J\u00f8rgensen MM. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J Extracell Vesicles. 2015;4:26659. https:\/\/doi.org\/10.3402\/jev.v4.26659.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR89","doi-asserted-by":"publisher","unstructured":"Wang Z, Wu H, Fine D, Schmulen J, Hu Y, Godin B, et al. Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip. 2013;13:2879\u201382. https:\/\/doi.org\/10.1039\/C3LC41343H.","DOI":"10.1039\/C3LC41343H"},{"key":"4095_CR90","doi-asserted-by":"publisher","unstructured":"B\u00f6ing AN, van der Pol E, Grootemaat AE, Coumans FAW, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3. https:\/\/doi.org\/10.3402\/jev.v3.23430.","DOI":"10.3402\/jev.v3.23430"},{"key":"4095_CR91","doi-asserted-by":"publisher","first-page":"24316","DOI":"10.1038\/srep24316","volume":"6","author":"BW S\u00f3dar","year":"2016","unstructured":"S\u00f3dar BW, Kittel \u00c1, P\u00e1l\u00f3czi K, Vukman KV, Osteikoetxea X, Szab\u00f3-Taylor K, et al. Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Sci Rep. 2016;6:24316. https:\/\/doi.org\/10.1038\/srep24316.","journal-title":"Sci Rep"},{"key":"4095_CR92","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.27031","volume":"4","author":"RJ Lobb","year":"2015","unstructured":"Lobb RJ, Becker M, Wen SW, Wong CSF, Wiegmans AP, Leimgruber A, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031. https:\/\/doi.org\/10.3402\/jev.v4.27031.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/srep33641","volume":"6","author":"A G\u00e1mez-Valero","year":"2016","unstructured":"G\u00e1mez-Valero A, Mongui\u00f3-Tortajada M, Carreras-Planella L, Franquesa M, Beyer K, Borr\u00e0s FE. Size-exclusion chromatography-based isolation minimally alters extracellular vesicles\u2019 characteristics compared to precipitating agents. Sci Rep. 2016;6:33641. https:\/\/doi.org\/10.1038\/srep33641.","journal-title":"Sci Rep"},{"key":"4095_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02599-y","volume":"7","author":"G Vergauwen","year":"2017","unstructured":"Vergauwen G, Dhondt B, Van Deun J, De Smedt E, Berx G, Timmerman E, et al. Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research. Sci Rep. 2017;7:2704. https:\/\/doi.org\/10.1038\/s41598-017-02599-y.","journal-title":"Sci Rep"},{"key":"4095_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201702153","volume":"14","author":"K Boriachek","year":"2018","unstructured":"Boriachek K, Islam M, M\u00f6ller A, Salomon C, Nguyen N-T, Hossain M, et al. Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small. 2018;14:1702153. https:\/\/doi.org\/10.1002\/smll.201702153.","journal-title":"Small"},{"key":"4095_CR96","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0019-2791(71)90454-X","volume":"8","author":"E Engvall","year":"1971","unstructured":"Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry. 1971;8:871\u20134. https:\/\/doi.org\/10.1016\/0019-2791(71)90454-X.","journal-title":"Immunochemistry"},{"key":"4095_CR97","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymeth.2015.05.028","volume":"87","author":"N Zarovni","year":"2015","unstructured":"Zarovni N, Corrado A, Guazzi P, Zocco D, Lari E, Radano G, et al. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods. 2015;87:46\u201358. https:\/\/doi.org\/10.1016\/j.ymeth.2015.05.028.","journal-title":"Methods"},{"key":"4095_CR98","doi-asserted-by":"publisher","unstructured":"Logozzi M, Milito AD, Lugini L, Borghi M, Calabr\u00f2 L, Spada M, et al. High levels of exosomes expressing CD63 and Caveolin-1 in plasma of melanoma patients. PLoS One. 2009;4:e5219. https:\/\/doi.org\/10.1371\/journal.pone.0005219.","DOI":"10.1371\/journal.pone.0005219"},{"key":"4095_CR99","doi-asserted-by":"publisher","unstructured":"L\u00e4sser C, Eldh M, L\u00f6tvall J. Isolation and Characterization of RNA-Containing Exosomes. Journal of Visualized Experiments (JoVE). 2012;e3037. https:\/\/doi.org\/10.3791\/3037.","DOI":"10.3791\/3037"},{"key":"4095_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0753-x","volume":"18","author":"BN Hannafon","year":"2016","unstructured":"Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, et al. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res. 2016;18:90. https:\/\/doi.org\/10.1186\/s13058-016-0753-x.","journal-title":"Breast Cancer Res"},{"key":"4095_CR101","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cyto.a.22795","volume":"89","author":"U Erdbr\u00fcgger","year":"2016","unstructured":"Erdbr\u00fcgger U, Lannigan J. Analytical challenges of extracellular vesicle detection: a comparison of different techniques. Cytometry A. 2016;89:123\u201334. https:\/\/doi.org\/10.1002\/cyto.a.22795.","journal-title":"Cytometry A"},{"key":"4095_CR102","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00001721-200207000-00003","volume":"13","author":"HK Kim","year":"2002","unstructured":"Kim HK, Song KS, Lee ES, Lee YJ, Park YS, Lee KR, et al. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagul Fibrinolysis. 2002;13:393\u20137. https:\/\/doi.org\/10.1097\/00001721-200207000-00003.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"4095_CR103","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1096\/fj.08-119131","volume":"23","author":"M Kesimer","year":"2009","unstructured":"Kesimer M, Scull M, Brighton B, DeMaria G, Burns K, O\u2019Neal W, et al. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 2009;23:1858\u201368. https:\/\/doi.org\/10.1096\/fj.08-119131.","journal-title":"FASEB J"},{"key":"4095_CR104","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1073\/pnas.69.7.1934","volume":"69","author":"MH Julius","year":"1972","unstructured":"Julius MH, Masuda T, Herzenberg LA. Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A. 1972;69:1934\u20138. https:\/\/doi.org\/10.1073\/pnas.69.7.1934.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4095_CR105","doi-asserted-by":"publisher","unstructured":"Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles. PLOS ONE. Public Library of Science; 2008;3:e3694. https:\/\/doi.org\/10.1371\/journal.pone.0003694.","DOI":"10.1371\/journal.pone.0003694"},{"key":"4095_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21:56. https:\/\/doi.org\/10.1186\/s12943-022-01509-9.","journal-title":"Mol Cancer"},{"key":"4095_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.120657","volume":"211","author":"SL Moura","year":"2020","unstructured":"Moura SL, Mart\u00edn CG, Mart\u00ed M, Pividori MI. Multiplex detection and characterization of breast cancer exosomes by magneto-actuated immunoassay. Talanta. 2020;211:120657. https:\/\/doi.org\/10.1016\/j.talanta.2019.120657.","journal-title":"Talanta"},{"key":"4095_CR108","doi-asserted-by":"publisher","first-page":"10998","DOI":"10.1021\/nn505162u","volume":"8","author":"S Zhu","year":"2014","unstructured":"Zhu S, Ma L, Wang S, Chen C, Zhang W, Yang L, et al. Light-scattering detection below the level of single fluorescent molecules for high-resolution characterization of functional nanoparticles. ACS Nano. 2014;8:10998\u20131006. https:\/\/doi.org\/10.1021\/nn505162u.","journal-title":"ACS Nano"},{"key":"4095_CR109","first-page":"45","volume":"14","author":"B Carr","year":"2009","unstructured":"Carr B, Hole P, Malloy A, Nelson P, Wright M, Smith J. Applications of nanoparticle tracking analysis in nanoparticle research - a mini review. Eur J Parenter Pharm Sci. 2009;14:45\u201350.","journal-title":"Eur J Parenter Pharm Sci"},{"key":"4095_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70393-4","volume":"10","author":"Y Risha","year":"2020","unstructured":"Risha Y, Minic Z, Ghobadloo SM, Berezovski MV. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers. Sci Rep. 2020;10:13572. https:\/\/doi.org\/10.1038\/s41598-020-70393-4.","journal-title":"Sci Rep"},{"key":"4095_CR111","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-4939-6728-5_2","volume":"1545","author":"SLN Maas","year":"2017","unstructured":"Maas SLN, Broekman MLD, de Vrij J. Tunable resistive pulse sensing for the characterization of extracellular vesicles. Methods Mol Biol. 2017;1545:21\u201333. https:\/\/doi.org\/10.1007\/978-1-4939-6728-5_2.","journal-title":"Methods Mol Biol"},{"key":"4095_CR112","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1021\/ac200195n","volume":"83","author":"R Vogel","year":"2011","unstructured":"Vogel R, Willmott G, Kozak D, Roberts GS, Anderson W, Groenewegen L, et al. Quantitative sizing of nano\/microparticles with a tunable elastomeric pore sensor. Anal Chem. 2011;83:3499\u2013506. https:\/\/doi.org\/10.1021\/ac200195n.","journal-title":"Anal Chem"},{"key":"4095_CR113","doi-asserted-by":"publisher","first-page":"31242","DOI":"10.3402\/jev.v5.31242","volume":"5","author":"R Vogel","year":"2016","unstructured":"Vogel R, Coumans FAW, Maltesen RG, B\u00f6ing AN, Bonnington KE, Broekman ML, et al. A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensing. J Extracell Vesicles. 2016;5:31242. https:\/\/doi.org\/10.3402\/jev.v5.31242.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR114","doi-asserted-by":"publisher","first-page":"12614","DOI":"10.1021\/acs.analchem.2c01216","volume":"94","author":"R Jia","year":"2022","unstructured":"Jia R, Rotenberg SA, Mirkin MV. Electrochemical resistive-pulse sensing of extracellular vesicles. Anal Chem. 2022;94:12614\u201320. https:\/\/doi.org\/10.1021\/acs.analchem.2c01216.","journal-title":"Anal Chem"},{"key":"4095_CR115","doi-asserted-by":"publisher","unstructured":"Coumans FAW, van der Pol E, B\u00f6ing AN, Hajji N, Sturk G, van Leeuwen TG, et al. Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing. Journal of Extracellular Vesicles. Taylor & Francis; 2014;3:25922. https:\/\/doi.org\/10.3402\/jev.v3.25922.","DOI":"10.3402\/jev.v3.25922"},{"key":"4095_CR116","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1039\/B701816A","volume":"132","author":"KJ Odenthal","year":"2007","unstructured":"Odenthal KJ, Gooding JJ. An introduction to electrochemical DNAbiosensors. Analyst. 2007;132:603\u201310. https:\/\/doi.org\/10.1039\/B701816A.","journal-title":"Analyst"},{"key":"4095_CR117","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1021\/acsnano.5b07584","volume":"10","author":"S Jeong","year":"2016","unstructured":"Jeong S, Park J, Pathania D, Castro CM, Weissleder R, Lee H. Integrated magneto-electrochemical sensor for exosome analysis. ACS Nano. 2016;10:1802\u20139. https:\/\/doi.org\/10.1021\/acsnano.5b07584.","journal-title":"ACS Nano"},{"key":"4095_CR118","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.1021\/acs.analchem.6b02421","volume":"88","author":"X Dold\u00e1n","year":"2016","unstructured":"Dold\u00e1n X, Fag\u00fandez P, Cayota A, La\u00edz J, Tosar JP. Electrochemical sandwich immunosensor for determination of exosomes based on surface marker-mediated signal amplification. Anal Chem. 2016;88:10466\u201373. https:\/\/doi.org\/10.1021\/acs.analchem.6b02421.","journal-title":"Anal Chem"},{"key":"4095_CR119","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14737159.2020.1731308","volume":"20","author":"A Makler","year":"2020","unstructured":"Makler A, Asghar W. Exosomal biomarkers for cancer diagnosis and patient monitoring. Expert Rev Mol Diagn. 2020;20:387\u2013400. https:\/\/doi.org\/10.1080\/14737159.2020.1731308.","journal-title":"Expert Rev Mol Diagn"},{"key":"4095_CR120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1600-0897.2006.00435.x","volume":"56","author":"A Sabapatha","year":"2006","unstructured":"Sabapatha A, Gercel-Taylor C, Taylor DD. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol. 2006;56:345\u201355. https:\/\/doi.org\/10.1111\/j.1600-0897.2006.00435.x.","journal-title":"Am J Reprod Immunol"},{"key":"4095_CR121","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/prca.200800093","volume":"4","author":"ML Merchant","year":"2010","unstructured":"Merchant ML, Powell DW, Wilkey DW, Cummins TD, Deegens JK, Rood IM, et al. Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin Appl. 2010;4:84\u201396. https:\/\/doi.org\/10.1002\/prca.200800093.","journal-title":"Proteomics Clin Appl"},{"key":"4095_CR122","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.26913","volume":"3","author":"J L\u00f6tvall","year":"2014","unstructured":"L\u00f6tvall J, Hill AF, Hochberg F, Buz\u00e1s EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913. https:\/\/doi.org\/10.3402\/jev.v3.26913.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR123","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0022-1759(00)00321-5","volume":"247","author":"A Clayton","year":"2001","unstructured":"Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001;247:163\u201374. https:\/\/doi.org\/10.1016\/S0022-1759(00)00321-5.","journal-title":"J Immunol Methods"},{"key":"4095_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/bios15050302","volume":"15","author":"H Ma","year":"2025","unstructured":"Ma H, Li J, Gao M, Dong Y, Luo Y, Su S. An electrochemical aptasensor for accurate and sensitive detection of exosomes based on dual-probe recognition and hybridization chain reaction. Biosensors (Basel). 2025;15:302. https:\/\/doi.org\/10.3390\/bios15050302.","journal-title":"Biosensors (Basel)"},{"key":"4095_CR125","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-018-0201-1","volume":"20","author":"C Liu","year":"2018","unstructured":"Liu C, Yang Y, Wu Y. Recent advances in exosomal protein detection via liquid biopsy biosensors for cancer screening, diagnosis, and prognosis. AAPS J. 2018;20:41. https:\/\/doi.org\/10.1208\/s12248-018-0201-1.","journal-title":"AAPS J"},{"key":"4095_CR126","doi-asserted-by":"publisher","unstructured":"Serrano-Pertierra E, Oliveira-Rodr\u00edguez M, Rivas M, Oliva P, Villafani J, Navarro A, et al. Characterization of Plasma-Derived Extracellular Vesicles Isolated by Different Methods: A Comparison Study. Bioengineering [Internet]. publisher; 2019 [cited 2025 Dec 26];6. https:\/\/doi.org\/10.3390\/bioengineering6010008.","DOI":"10.3390\/bioengineering6010008"},{"key":"4095_CR127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231994","volume":"16","author":"TS Lyu","year":"2021","unstructured":"Lyu TS, Ahn Y, Im Y-J, Kim S-S, Lee K-H, Kim J, et al. The characterization of exosomes from fibrosarcoma cell and the useful usage of Dynamic Light Scattering (DLS) for their evaluation. PLoS One. 2021;16:e0231994. https:\/\/doi.org\/10.1371\/journal.pone.0231994.","journal-title":"PLoS One"},{"key":"4095_CR128","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11051-008-9435-7","volume":"10","author":"CM Hoo","year":"2008","unstructured":"Hoo CM, Starostin N, West P, Mecartney ML. A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions. J Nanopart Res. 2008;10:89\u201396. https:\/\/doi.org\/10.1007\/s11051-008-9435-7.","journal-title":"J Nanopart Res"},{"key":"4095_CR129","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1021\/la00007a028","volume":"11","author":"G Bryant","year":"1995","unstructured":"Bryant G, Thomas JC. Improved particle size distribution measurements using multiangle dynamic light scattering. Langmuir. 1995;11:2480\u20135. https:\/\/doi.org\/10.1021\/la00007a028.","journal-title":"Langmuir"},{"key":"4095_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120148","volume":"568","author":"B Chen","year":"2025","unstructured":"Chen B, Qiu X. Surface-enhanced raman scattering (SERS) for exosome detection. Clin Chim Acta. 2025;568:120148. https:\/\/doi.org\/10.1016\/j.cca.2025.120148.","journal-title":"Clin Chim Acta"},{"key":"4095_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24162947","volume":"24","author":"P Zhang","year":"2019","unstructured":"Zhang P, Wang L, Fang Y, Zheng D, Lin T, Wang H. Label-free exosomal detection and classification in rapid discriminating different cancer types based on specific raman phenotypes and multivariate statistical analysis. Molecules. 2019;24:2947. https:\/\/doi.org\/10.3390\/molecules24162947.","journal-title":"Molecules"},{"key":"4095_CR132","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.1021\/acs.nanolett.2c02928","volume":"22","author":"Y Xie","year":"2022","unstructured":"Xie Y, Su X, Wen Y, Zheng C, Li M, American Chemical Society. Artificial intelligent label-free SERS profiling of serum exosomes for breast cancer diagnosis and postoperative assessment. Nano Lett. 2022;22:7910\u20138. https:\/\/doi.org\/10.1021\/acs.nanolett.2c02928.","journal-title":"Nano Lett"},{"key":"4095_CR133","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nbt.2886","volume":"32","author":"H Im","year":"2014","unstructured":"Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014;32:490\u20135. https:\/\/doi.org\/10.1038\/nbt.2886.","journal-title":"Nat Biotechnol"},{"key":"4095_CR134","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00216-019-01608-5","volume":"411","author":"AAI Sina","year":"2019","unstructured":"Sina AAI, Vaidyanathan R, Wuethrich A, Carrascosa LG, Trau M. Label-free detection of exosomes using a surface plasmon resonance biosensor. Anal Bioanal Chem. 2019;411:1311\u20138. https:\/\/doi.org\/10.1007\/s00216-019-01608-5.","journal-title":"Anal Bioanal Chem"},{"key":"4095_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1835","volume":"15","author":"KP De Sousa","year":"2023","unstructured":"De Sousa KP, Rossi I, Abdullahi M, Ramirez MI, Stratton D, Inal JM. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15:e1835. https:\/\/doi.org\/10.1002\/wnan.1835.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4095_CR136","doi-asserted-by":"publisher","unstructured":"Kalimuthu S, Gangadaran P, Rajendran RL, Zhu L, Oh JM, Lee HW, et al. A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.01116.","DOI":"10.3389\/fphar.2018.01116"},{"key":"4095_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121646","volume":"322","author":"S Farhadi","year":"2023","unstructured":"Farhadi S, Mohammadi-Yeganeh S, Kiani J, Hashemi SM, Koochaki A, Sharifi K, et al. Exosomal delivery of 7SK long non-coding RNA suppresses viability, proliferation, aggressiveness and tumorigenicity in triple negative breast cancer cells. Life Sci. 2023;322:121646. https:\/\/doi.org\/10.1016\/j.lfs.2023.121646.","journal-title":"Life Sci"},{"key":"4095_CR138","doi-asserted-by":"publisher","first-page":"723","DOI":"10.22038\/IJBMS.2022.64092.14116","volume":"25","author":"M Ebrahimian","year":"2022","unstructured":"Ebrahimian M, Hashemi M, Etemad L, Salmasi Z. Thymoquinone-loaded mesenchymal stem cell-derived exosome as an efficient nano-system against breast cancer cells. Iran J Basic Med Sci. 2022;25:723\u201331. https:\/\/doi.org\/10.22038\/IJBMS.2022.64092.14116.","journal-title":"Iran J Basic Med Sci"},{"key":"4095_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110771","volume":"131","author":"J Donoso-Quezada","year":"2020","unstructured":"Donoso-Quezada J, Guajardo-Flores D, Gonz\u00e1lez-Valdez J. Enhanced exosome-mediated delivery of black bean phytochemicals (Phaseolus vulgaris L.) for cancer treatment applications. Biomed Pharmacother. 2020;131:110771. https:\/\/doi.org\/10.1016\/j.biopha.2020.110771.","journal-title":"Biomed Pharmacother"},{"key":"4095_CR140","doi-asserted-by":"publisher","unstructured":"Jang J-Y, Lee J-K, Jeon Y-K, Kim C-W. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC Cancer [Internet]. Springer Science and Business Media LLC; 2013;13. https:\/\/doi.org\/10.1186\/1471-2407-13-421.","DOI":"10.1186\/1471-2407-13-421"},{"key":"4095_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","volume":"318","author":"L Zhao","year":"2020","unstructured":"Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H. Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis. J Control Release. 2020;318:1\u201315. https:\/\/doi.org\/10.1016\/j.jconrel.2019.12.005.","journal-title":"J Control Release"},{"key":"4095_CR142","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12257-020-0002-0","volume":"25","author":"H Kim","year":"2020","unstructured":"Kim H, Rhee WJ. Exosome-mediated Let7c-5p delivery for breast cancer therapeutic development. Biotechnol Bioprocess Eng. 2020;25:513\u201320. https:\/\/doi.org\/10.1007\/s12257-020-0002-0.","journal-title":"Biotechnol Bioprocess Eng"},{"key":"4095_CR143","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2217\/nnm-2022-0237","volume":"18","author":"ZS Hashemi","year":"2023","unstructured":"Hashemi ZS, Ghavami M, Kiaie SH, Mohammadi F, Barough MS, Khalili S, et al. Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer. Nanomedicine (Lond). 2023;18:437\u201353. https:\/\/doi.org\/10.2217\/nnm-2022-0237.","journal-title":"Nanomedicine (Lond)"},{"key":"4095_CR144","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jconrel.2023.11.051","volume":"365","author":"Y Yu","year":"2024","unstructured":"Yu Y, Li T, Ou M, Luo R, Chen H, Ren H, et al. OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy. J Control Release. 2024;365:469\u201379. https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.051.","journal-title":"J Control Release"},{"key":"4095_CR145","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","volume":"21","author":"L Huang","year":"2022","unstructured":"Huang L, Rong Y, Tang X, Yi K, Qi P, Hou J, et al. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Mol Cancer. 2022;21:45. https:\/\/doi.org\/10.1186\/s12943-022-01515-x.","journal-title":"Mol Cancer"},{"key":"4095_CR146","doi-asserted-by":"publisher","unstructured":"Llevenes P, Chen A, Lawton M, Rond\u00f3n-Ortiz AN, Qiu Y, Seen M, et al. Plasma Exosomes in Insulin Resistant Obesity Exacerbate Progression of Triple Negative Breast Cancer. bioRxiv. 2025;2024.10.10.617639. https:\/\/doi.org\/10.1101\/2024.10.10.617639.","DOI":"10.1101\/2024.10.10.617639"},{"key":"4095_CR147","doi-asserted-by":"publisher","first-page":"263","DOI":"10.61186\/rbmb.13.2.263","volume":"13","author":"S Shadi Vaziri","year":"2024","unstructured":"Shadi Vaziri S, Tajbakhsh E, Khamesipour F, Momtaz H, Mazaheri Z. Impact of Helicobacter pylori-derived outer membrane vesicles on inflammation, immune responses, and tumor cell migration in breast cancer through the snail\/\u0392-catenin pathway. Rep Biochem Mol Biol. 2024;13:263\u201372. https:\/\/doi.org\/10.61186\/rbmb.13.2.263.","journal-title":"Rep Biochem Mol Biol"},{"key":"4095_CR148","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bioactmat.2022.05.037","volume":"20","author":"Y Li","year":"2023","unstructured":"Li Y, Wu J, Qiu X, Dong S, He J, Liu J, et al. Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic\/chemo-\/immunotherapy. Bioact Mater. 2023;20:548\u201360. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.05.037.","journal-title":"Bioact Mater"},{"key":"4095_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11072030","volume":"11","author":"J An","year":"2022","unstructured":"An J, Kwon H, Lim W, Moon B-I. Staphylococcus aureus-derived extracellular vesicles enhance the efficacy of endocrine therapy in breast cancer cells. J Clin Med. 2022;11:2030. https:\/\/doi.org\/10.3390\/jcm11072030.","journal-title":"J Clin Med"},{"key":"4095_CR150","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Sarr\u00edas A, Iglesias-Aguirre CE, Cort\u00e9s-Mart\u00edn A, Vallejo F, Cattivelli A, del Pozo-Acebo L, et al. Milk-Derived Exosomes as Nanocarriers to Deliver Curcumin and Resveratrol in Breast Tissue and Enhance Their Anticancer Activity. International Journal of Molecular Sciences. MDPI AG; 2022;23:2860. https:\/\/doi.org\/10.3390\/ijms23052860.","DOI":"10.3390\/ijms23052860"},{"key":"4095_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2025.111644","volume":"199","author":"P Gupta","year":"2025","unstructured":"Gupta P, Marwaha D, Sharma S, Sethi VA. Hypothesizing the co-delivery of raloxifene and genistein by bovine milk exosomes for enhanced drug delivery in breast cancer management. Med Hypotheses. 2025;199:111644. https:\/\/doi.org\/10.1016\/j.mehy.2025.111644.","journal-title":"Med Hypotheses"},{"key":"4095_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.114102","volume":"182","author":"R Anusha","year":"2023","unstructured":"Anusha R, Ashin M, Priya S. Ginger exosome-like nanoparticles (GELNs) induced apoptosis, cell cycle arrest, and anti-metastatic effects in triple-negative breast cancer MDA-MB-231 cells. Food Chem Toxicol. 2023;182:114102. https:\/\/doi.org\/10.1016\/j.fct.2023.114102.","journal-title":"Food Chem Toxicol"},{"key":"4095_CR153","doi-asserted-by":"publisher","unstructured":"Salem D, Abdel-Ghany S, Mohamed E, Alahmady N, Alqosaibi A, Al-Dhuayan I, et al. Natural nanoparticles for drug delivery: proteomic insights and anticancer potential of doxorubicin-loaded avocado exosomes. Pharmaceuticals. 2025;18:844. https:\/\/doi.org\/10.3390\/ph18060844.","DOI":"10.3390\/ph18060844"},{"key":"4095_CR154","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.apsb.2021.08.016","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li Q, Liang Y, Zu M, Chen N, Canup BSB, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharmaceutica Sinica B Elsevier BV. 2022;12:907\u201323. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.016.","journal-title":"Acta Pharmaceutica Sinica B Elsevier BV"},{"key":"4095_CR155","doi-asserted-by":"publisher","unstructured":"Chen Q, Zu M, Gong H, Ma Y, Sun J, Ran S, et al. Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation. J Nanobiotechnology. 2023. https:\/\/doi.org\/10.1186\/s12951-022-01755-5.","DOI":"10.1186\/s12951-022-01755-5"},{"key":"4095_CR156","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ymthe.2021.08.028","volume":"30","author":"X Han","year":"2022","unstructured":"Han X, Wei Q, Lv Y, Weng L, Huang H, Wei Q, et al. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Mol Ther. 2022;30:327\u201340. https:\/\/doi.org\/10.1016\/j.ymthe.2021.08.028.","journal-title":"Mol Ther"},{"key":"4095_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1390708","author":"L Cui","year":"2024","unstructured":"Cui L, Perini G, Augello A, Palmieri V, De Spirito M, Papi M. Plant-derived extracellular nanovesicles: a promising biomedical approach for effective targeting of triple negative breast cancer cells. Front Bioeng Biotechnol. 2024. https:\/\/doi.org\/10.3389\/fbioe.2024.1390708.","journal-title":"Front Bioeng Biotechnol"},{"key":"4095_CR158","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C, Annual Reviews. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255\u201389. https:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122326.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4095_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03245-3","volume":"14","author":"GRL Al-Awsi","year":"2023","unstructured":"Al-Awsi GRL, Alsaikhan F, Margiana R, Ahmad I, Patra I, Najm MAA, et al. Shining the light on mesenchymal stem cell-derived exosomes in breast cancer. Stem Cell Res Ther. 2023;14:21. https:\/\/doi.org\/10.1186\/s13287-023-03245-3.","journal-title":"Stem Cell Res Ther"},{"key":"4095_CR160","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2021.11.015","volume":"526","author":"F Zhang","year":"2022","unstructured":"Zhang F, Guo J, Zhang Z, Qian Y, Wang G, Duan M, et al. Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy. Cancer Lett. 2022;526:29\u201340. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.015.","journal-title":"Cancer Lett"},{"key":"4095_CR161","doi-asserted-by":"publisher","DOI":"10.1177\/09636897231220073","volume":"32","author":"L Zhang","year":"2023","unstructured":"Zhang L. The role of mesenchymal stem cells in modulating the breast cancer microenvironment. Cell Transplant. 2023;32:09636897231220073. https:\/\/doi.org\/10.1177\/09636897231220073.","journal-title":"Cell Transplant"},{"key":"4095_CR162","doi-asserted-by":"publisher","DOI":"10.3390\/biology14030313","volume":"14","author":"EF Wiest","year":"2025","unstructured":"Wiest EF, Zubair AC, Multidisciplinary Digital Publishing Institute. Generation of Current Good Manufacturing Practices-Grade Mesenchymal Stromal Cell-Derived Extracellular Vesicles Using Automated Bioreactors. Biology (Basel). 2025;14:313. https:\/\/doi.org\/10.3390\/biology14030313.","journal-title":"Biology (Basel)"},{"key":"4095_CR163","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.7150\/thno.18752","volume":"7","author":"L Zhu","year":"2017","unstructured":"Zhu L, Kalimuthu S, Gangadaran P, Oh JM, Lee HW, Baek SH, et al. Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics. 2017;7:2732\u201345. https:\/\/doi.org\/10.7150\/thno.18752.","journal-title":"Theranostics"},{"key":"4095_CR164","doi-asserted-by":"publisher","unstructured":"Luo H, Zhou Y, Zhang J, Zhang Y, Long S, Lin X, et al. Nk cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions. Front Immunol [Internet]. 2023. https:\/\/doi.org\/10.3389\/fimmu.2022.1087689.","DOI":"10.3389\/fimmu.2022.1087689"},{"key":"4095_CR165","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02965-1","author":"A Zhang","year":"2025","unstructured":"Zhang A, Yin X, Ma J, Springer Science and Business Media LLC. NK-derived exosomes in anti-tumor strategies. Medical Oncology [Internet]. 2025. https:\/\/doi.org\/10.1007\/s12032-025-02965-1.","journal-title":"Medical Oncology [Internet]"},{"key":"4095_CR166","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14:195\u2013208. https:\/\/doi.org\/10.1038\/nri3622.","journal-title":"Nat Rev Immunol"},{"key":"4095_CR167","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0598-594","volume":"4","author":"L Zitvogel","year":"1998","unstructured":"Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4:594\u2013600. https:\/\/doi.org\/10.1038\/nm0598-594.","journal-title":"Nat Med"},{"key":"4095_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171428","volume":"13","author":"W Zhou","year":"2024","unstructured":"Zhou W, Yang F, Zhang X. Roles of M1 macrophages and their extracellular vesicles in cancer therapy. Cells. 2024;13:1428. https:\/\/doi.org\/10.3390\/cells13171428.","journal-title":"Cells"},{"key":"4095_CR169","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12951-025-03321-1","volume":"23","author":"L Liu","year":"2025","unstructured":"Liu L, Zhang S, Ren Y, Wang R, Zhang Y, Weng S, et al. Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential. J Nanobiotechnol. 2025;23:319. https:\/\/doi.org\/10.1186\/s12951-025-03321-1.","journal-title":"J Nanobiotechnol"},{"key":"4095_CR170","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","volume":"118","author":"H Shao","year":"2018","unstructured":"Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118:1917\u201350. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00534.","journal-title":"Chem Rev"},{"key":"4095_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112657","volume":"147","author":"S Bai","year":"2022","unstructured":"Bai S, Wei Y, Liu R, Xu R, Xiang L, Du J. Role of tumour-derived exosomes in metastasis. Biomed Pharmacother. 2022;147:112657. https:\/\/doi.org\/10.1016\/j.biopha.2022.112657.","journal-title":"Biomed Pharmacother"},{"key":"4095_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107751","volume":"217","author":"X Wu","year":"2025","unstructured":"Wu X, Meng Y, Yao Z, Lin X, Hu M, Cai S, et al. Extracellular vesicles as nature\u2019s nano carriers in cancer therapy: insights toward preclinical studies and clinical applications. Pharmacol Res. 2025;217:107751. https:\/\/doi.org\/10.1016\/j.phrs.2025.107751.","journal-title":"Pharmacol Res"},{"key":"4095_CR173","doi-asserted-by":"publisher","unstructured":"Ni C, Fang Q-Q, Chen W-Z, Jiang J-X, Jiang Z, Ye J, et al. Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+\u03b3\u03b41 Treg cells. Sig Transduct Target Ther. 2020;5:41. https:\/\/doi.org\/10.1038\/s41392-020-0129-7.","DOI":"10.1038\/s41392-020-0129-7"},{"key":"4095_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100913","volume":"24","author":"J Ding","year":"2024","unstructured":"Ding J, Ding X, Liao W, Lu Z. Red blood cell-derived materials for cancer therapy: construction, distribution, and applications. Mater Today Bio. 2024;24:100913. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100913.","journal-title":"Mater Today Bio"},{"key":"4095_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102798","volume":"11","author":"S-R Ma","year":"2023","unstructured":"Ma S-R, Xia H-F, Gong P, Yu Z-L. Red Blood Cell-Derived Extracellular Vesicles: an overview of current research progress, challenges, and opportunities. Biomedicines. 2023;11:2798. https:\/\/doi.org\/10.3390\/biomedicines11102798.","journal-title":"Biomedicines"},{"key":"4095_CR176","doi-asserted-by":"publisher","unstructured":"Romano M, Music\u00f2 A, Zendrini A, Gilberti E, Orlandi F, Pedrazzi T, et al. Red Blood Cell-derived Extracellular Vesicles enable Cisplatin and Cetuximab Synergistic Therapy against Triple-Negative Breast Cancer [Internet]. bioRxiv; 2025 [cited 2025 Oct 8]. p. 2025.03.20.644320. https:\/\/doi.org\/10.1101\/2025.03.20.644320","DOI":"10.1101\/2025.03.20.644320"},{"key":"4095_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101277","volume":"83","author":"Q-Q Chai","year":"2025","unstructured":"Chai Q-Q, Li D, Zhang M, Gu Y-W, Li A-X, Wu X, et al. Engineering nanoplatforms of bacterial outer membrane vesicles to overcome cancer therapy resistance. Drug Resist Updates. 2025;83:101277. https:\/\/doi.org\/10.1016\/j.drup.2025.101277.","journal-title":"Drug Resist Updates"},{"key":"4095_CR178","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20253004","volume":"69","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wu Y. Potential of bacterial outer membrane vesicles in tumor vaccine: characteristics, advancements, and future directions. Essays Biochem. 2025;69:EBC20253004. https:\/\/doi.org\/10.1042\/EBC20253004.","journal-title":"Essays Biochem"},{"key":"4095_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-023-06506-9","volume":"16","author":"H Cao","year":"2023","unstructured":"Cao H. Bacterial endotoxin lipopolysaccharides regulate gene expression in human colon cancer cells. BMC Res Notes. 2023;16:216. https:\/\/doi.org\/10.1186\/s13104-023-06506-9.","journal-title":"BMC Res Notes"},{"key":"4095_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.719289","author":"Z Sepahdar","year":"2021","unstructured":"Sepahdar Z, Miroliaei M, Bouzari S, Khalaj V, Salimi M, Frontiers. Surface engineering of Escherichia coli\u2013derived OMVs as promising nano-carriers to target EGFR-overexpressing breast cancer cells. Front Pharmacol [Internet]. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.719289.","journal-title":"Front Pharmacol [Internet]"},{"key":"4095_CR181","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1007\/s11033-023-08702-z","volume":"50","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Wang L, Yang B, Ma G, Chen Z, Ma J, et al. Bifidobacterium-derived membrane vesicles inhibit triple-negative breast cancer growth by inducing tumor cell apoptosis. Mol Biol Rep. 2023;50:7547\u201356. https:\/\/doi.org\/10.1007\/s11033-023-08702-z.","journal-title":"Mol Biol Rep"},{"key":"4095_CR182","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/bph.15421","volume":"178","author":"L del Pozo\u2010Acebo","year":"2021","unstructured":"del Pozo\u2010Acebo L, L\u00f3pez de las Hazas M, Margoll\u00e9s A, D\u00e1valos A, Garc\u00eda\u2010Ruiz A, Wiley. Eating microRNAs: pharmacological opportunities for cross\u2010kingdom regulation and implications in host gene and gut microbiota modulation. Br J Pharmacol. 2021;178:2218\u201345. https:\/\/doi.org\/10.1111\/bph.15421.","journal-title":"Br J Pharmacol"},{"key":"4095_CR183","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.bioactmat.2021.01.009","volume":"6","author":"B Adriano","year":"2021","unstructured":"Adriano B, Cotto NM, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM, et al. Milk exosomes: nature\u2019s abundant nanoplatform for theranostic applications. Bioact Mater. 2021;6:2479\u201390. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.01.009.","journal-title":"Bioact Mater"},{"key":"4095_CR184","doi-asserted-by":"publisher","unstructured":"L\u00f3pez de las Hazas M-C, del Pozo-Acebo L, Hansen MS, Gil-Zamorano J, Mantilla-Escalante DC, G\u00f3mez-Coronado D, et al. Dietary bovine milk miRNAs transported in extracellular vesicles are partially stable during GI digestion, are bioavailable and reach target tissues but need a minimum dose to impact on gene expression. Eur J Nutr. 2021;61:1043\u201356. https:\/\/doi.org\/10.1007\/s00394-021-02720-y.","DOI":"10.1007\/s00394-021-02720-y"},{"key":"4095_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210194","volume":"24","author":"AM Timofeeva","year":"2023","unstructured":"Timofeeva AM, Paramonik AP, Sedykh SS, Nevinsky GA, Multidisciplinary Digital Publishing Institute. Milk exosomes: next-generation agents for delivery of anticancer drugs and therapeutic nucleic acids. Int J Mol Sci. 2023;24:10194. https:\/\/doi.org\/10.3390\/ijms241210194.","journal-title":"Int J Mol Sci"},{"key":"4095_CR186","doi-asserted-by":"publisher","unstructured":"Suharta S, Barlian A, Hidajah AC, Notobroto HB, Ana ID, Indariani S, et al. Plant\u2010derived exosome\u2010like nanoparticles: a concise review on its extraction methods, content, bioactivities, and potential as functional food ingredient. J Food Sci. 2021;86:2838\u201350. https:\/\/doi.org\/10.1111\/1750-3841.15787.","DOI":"10.1111\/1750-3841.15787"},{"key":"4095_CR187","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13904","volume":"17","author":"C Wang","year":"2024","unstructured":"Wang C, Tsai T, Lee C. Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024;17:e13904. https:\/\/doi.org\/10.1111\/cts.13904.","journal-title":"Clin Transl Sci"},{"key":"4095_CR188","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","volume":"6","author":"D Ha","year":"2016","unstructured":"Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6:287\u201396. https:\/\/doi.org\/10.1016\/j.apsb.2016.02.001.","journal-title":"Acta Pharm Sin B"},{"key":"4095_CR189","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","author":"S EL Andaloussi","year":"2013","unstructured":"EL Andaloussi S, M\u00e4ger I, Breakefield XO, Wood MJA. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347\u201357. https:\/\/doi.org\/10.1038\/nrd3978.","journal-title":"Nat Rev Drug Discov"},{"key":"4095_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061435","volume":"14","author":"DN Kumar","year":"2022","unstructured":"Kumar DN, Chaudhuri A, Aqil F, Dehari D, Munagala R, Singh S, et al. Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application. Cancers (Basel). 2022;14:1435. https:\/\/doi.org\/10.3390\/cancers14061435.","journal-title":"Cancers (Basel)"},{"key":"4095_CR191","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbcan.2014.04.005","volume":"1846","author":"KB Johnsen","year":"2014","unstructured":"Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta. 2014;1846:75\u201387. https:\/\/doi.org\/10.1016\/j.bbcan.2014.04.005.","journal-title":"Biochim Biophys Acta"},{"key":"4095_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1384946","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ma Q, Wang T, Xing J, Li Q, Wang D, et al. The involvement and application potential of exosomes in breast cancer immunotherapy. Front Immunol. 2024;15:1384946. https:\/\/doi.org\/10.3389\/fimmu.2024.1384946.","journal-title":"Front Immunol"},{"key":"4095_CR193","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498\u2013503. https:\/\/doi.org\/10.1038\/nature22341.","journal-title":"Nature"},{"key":"4095_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00363-1","volume":"12","author":"L Guo","year":"2023","unstructured":"Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, et al. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023;12:3. https:\/\/doi.org\/10.1186\/s40164-022-00363-1.","journal-title":"Exp Hematol Oncol"},{"key":"4095_CR195","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.addr.2020.06.015","volume":"157","author":"M Hashida","year":"2020","unstructured":"Hashida M. Role of pharmacokinetic consideration for the development of drug delivery systems: a historical overview. Adv Drug Deliv Rev. 2020;157:71\u201382. https:\/\/doi.org\/10.1016\/j.addr.2020.06.015.","journal-title":"Adv Drug Deliv Rev"},{"key":"4095_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101771","volume":"49","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Pandya A, Kumar L, Raval N, Vora LK, Pulakkat S, et al. Exosome nanovesicles: A potential carrier for therapeutic delivery. Nano Today. 2023;49:101771. https:\/\/doi.org\/10.1016\/j.nantod.2023.101771.","journal-title":"Nano Today"},{"key":"4095_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103628","volume":"172","author":"D Ferreira","year":"2022","unstructured":"Ferreira D, Moreira JN, Rodrigues LR. New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol Hematol. 2022;172:103628. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103628.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4095_CR198","doi-asserted-by":"publisher","first-page":"43374","DOI":"10.1021\/acsomega.3c04479","volume":"8","author":"L Huang","year":"2023","unstructured":"Huang L, Wu E, Liao J, Wei Z, Wang J, Chen Z, et al. Research advances of engineered exosomes as drug delivery carrier. ACS Omega. 2023;8:43374\u201387. https:\/\/doi.org\/10.1021\/acsomega.3c04479.","journal-title":"ACS Omega"},{"key":"4095_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107534","volume":"210","author":"JR Roskoski","year":"2024","unstructured":"Roskoski JR. Targeted and cytotoxic inhibitors used in the treatment of breast cancer. Pharmacol Res. 2024;210:107534. https:\/\/doi.org\/10.1016\/j.phrs.2024.107534.","journal-title":"Pharmacol Res"},{"key":"4095_CR200","doi-asserted-by":"publisher","unstructured":"Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine Nanotechnology Biol Med. 2016;12:655\u201364. https:\/\/doi.org\/10.1016\/j.nano.2015.10.012.","DOI":"10.1016\/j.nano.2015.10.012"},{"key":"4095_CR201","doi-asserted-by":"publisher","unstructured":"Liu M, Wang Y, Zhang Y, Hu D, Tang L, Zhou B, et al. Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. Sig Transduct Target Ther. 2025;10:73. https:\/\/doi.org\/10.1038\/s41392-024-02112-8.","DOI":"10.1038\/s41392-024-02112-8"},{"key":"4095_CR202","doi-asserted-by":"publisher","DOI":"10.1177\/11782234251355663","volume":"19","author":"Q Maqsood","year":"2025","unstructured":"Maqsood Q, Khan MU, Fatima T, Khalid S, Malik ZI. Recent insights into breast cancer: molecular pathways, epigenetic regulation, and emerging targeted therapies. Breast Cancer (Auckl). 2025;19:11782234251355663. https:\/\/doi.org\/10.1177\/11782234251355663.","journal-title":"Breast Cancer (Auckl)"},{"key":"4095_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2025.100210","volume":"26","author":"S Gautam","year":"2025","unstructured":"Gautam S, Maurya R, Vikal A, Patel P, Thakur S, Singh A, et al. Understanding drug resistance in breast cancer: Mechanisms and emerging therapeutic strategies. Medicine in Drug Discovery. 2025;26:100210. https:\/\/doi.org\/10.1016\/j.medidd.2025.100210.","journal-title":"Medicine in Drug Discovery"},{"key":"4095_CR204","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03325-7","volume":"20","author":"A Amiri","year":"2022","unstructured":"Amiri A, Bagherifar R, Ansari Dezfouli E, Kiaie SH, Jafari R, Ramezani R. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. J Transl Med. 2022;20:125. https:\/\/doi.org\/10.1186\/s12967-022-03325-7.","journal-title":"J Transl Med"},{"key":"4095_CR205","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-256","volume":"13","author":"R Singh","year":"2014","unstructured":"Singh R, Pochampally R, Watabe K, Lu Z, Mo Y-Y. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer. 2014;13:256. https:\/\/doi.org\/10.1186\/1476-4598-13-256.","journal-title":"Mol Cancer"},{"key":"4095_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071827","volume":"12","author":"GL Wong","year":"2020","unstructured":"Wong GL, Abu Jalboush S, Lo H-W. Exosomal MicroRNAs and organotropism in breast cancer metastasis. Cancers (Basel). 2020;12:1827. https:\/\/doi.org\/10.3390\/cancers12071827.","journal-title":"Cancers (Basel)"},{"key":"4095_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117853","volume":"183","author":"M Kulus","year":"2025","unstructured":"Kulus M, Farzaneh M, Sheykhi-Sabzehpoush M, Ghaedrahmati F, Mehravar F, J\u00f3zkowiak M, et al. Exosomes and non-coding RNAs: exploring their roles in human myocardial dysfunction. Biomed Pharmacother. 2025;183:117853. https:\/\/doi.org\/10.1016\/j.biopha.2025.117853.","journal-title":"Biomed Pharmacother"},{"key":"4095_CR208","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12951-024-02634-x","volume":"22","author":"Z Iqbal","year":"2024","unstructured":"Iqbal Z, Rehman K, Mahmood A, Shabbir M, Liang Y, Duan L, et al. Exosome for mRNA delivery: strategies and therapeutic applications. J Nanobiotechnology. 2024;22:395. https:\/\/doi.org\/10.1186\/s12951-024-02634-x.","journal-title":"J Nanobiotechnology"},{"key":"4095_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2022.100063","volume":"7","author":"A Paul","year":"2022","unstructured":"Paul A, Muralidharan A, Biswas A, Kamath BV, Joseph A, Alex AT. siRNA therapeutics and its challenges: recent advances in effective delivery for cancer therapy. Open Nano. 2022;7:100063. https:\/\/doi.org\/10.1016\/j.onano.2022.100063.","journal-title":"Open Nano"},{"key":"4095_CR210","doi-asserted-by":"publisher","first-page":"40767","DOI":"10.18632\/oncotarget.8194","volume":"7","author":"YK Chae","year":"2016","unstructured":"Chae YK, Arya A, Malecek M-K, Shin DS, Carneiro B, Chandra S, et al. Repurposing metformin for cancer treatment: current clinical studies. Oncotarget. 2016;7:40767\u201380. https:\/\/doi.org\/10.18632\/oncotarget.8194.","journal-title":"Oncotarget"},{"key":"4095_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03312-6","volume":"24","author":"R Abbasi","year":"2024","unstructured":"Abbasi R, Nejati V, Rezaie J. Exosomes biogenesis was increased in metformin-treated human ovary cancer cells; possibly to mediate resistance. Cancer Cell Int. 2024;24:137. https:\/\/doi.org\/10.1186\/s12935-024-03312-6.","journal-title":"Cancer Cell Int"},{"key":"4095_CR212","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.trecan.2020.11.008","volume":"7","author":"D Juarez","year":"2021","unstructured":"Juarez D, Fruman DA. Targeting the Mevalonate Pathway in Cancer. Trends Cancer. 2021;7:525\u201340. https:\/\/doi.org\/10.1016\/j.trecan.2020.11.008.","journal-title":"Trends Cancer"},{"key":"4095_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2022.104385","volume":"143","author":"E Valipour","year":"2022","unstructured":"Valipour E, Ranjbar FE, Mousavi M, Ai J, Malekshahi ZV, Mokhberian N, et al. The anti-angiogenic effect of atorvastatin loaded exosomes on glioblastoma tumor cells: An in vitro 3D culture model. Microvasc Res. 2022;143:104385. https:\/\/doi.org\/10.1016\/j.mvr.2022.104385.","journal-title":"Microvasc Res"},{"key":"4095_CR214","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12132","volume":"10","author":"MF Santos","year":"2021","unstructured":"Santos MF, Rappa G, Karbanov\u00e1 J, Fontana S, Bella MAD, Pope MR, et al. Itraconazole inhibits nuclear delivery of extracellular vesicle cargo by disrupting the entry of late endosomes into the nucleoplasmic reticulum. J Extracell Vesicles. 2021;10:e12132. https:\/\/doi.org\/10.1002\/jev2.12132.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR215","doi-asserted-by":"publisher","unstructured":"Jin M, Zeng B, Liu Y, Jin L, Hou Y, Liu C, et al. Co-delivery of repurposing Itraconazole and VEGF siRNA by composite nanoparticulate system for collaborative anti-angiogenesis and anti-tumor efficacy against breast cancer. Pharmaceutics. 2022;14:1369. https:\/\/doi.org\/10.3390\/pharmaceutics14071369.","DOI":"10.3390\/pharmaceutics14071369"},{"key":"4095_CR216","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/neuonc\/noac071","volume":"24","author":"Q Zhan","year":"2022","unstructured":"Zhan Q, Yi K, Cui X, Li X, Yang S, Wang Q, et al. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy. Neuro Oncol. 2022;24:1871\u201383. https:\/\/doi.org\/10.1093\/neuonc\/noac071.","journal-title":"Neuro Oncol"},{"key":"4095_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.574068","volume":"11","author":"L Yin","year":"2020","unstructured":"Yin L, He Z, Yi B, Xue L, Sun J. Simvastatin suppresses human breast cancer cell invasion by decreasing the expression of pituitary tumor-transforming gene 1. Front Pharmacol. 2020;11:574068. https:\/\/doi.org\/10.3389\/fphar.2020.574068.","journal-title":"Front Pharmacol"},{"key":"4095_CR218","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2478\/raon-2021-0020","volume":"55","author":"B Aschenbrenner","year":"2021","unstructured":"Aschenbrenner B, Negro G, Savic D, Sorokin M, Buzdin A, Ganswindt U, et al. Simvastatin Is Effective in Killing the Radioresistant Breast Carcinoma Cells. Radiol Oncol. 2021;55:305\u201316. https:\/\/doi.org\/10.2478\/raon-2021-0020.","journal-title":"Radiol Oncol"},{"key":"4095_CR219","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12951-024-02492-7","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y, Tang R, Cao Y, Wu N, Qin Q, Chen Y, et al. LIFU\/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer. Journal of Nanobiotechnology. 2024;22:209. https:\/\/doi.org\/10.1186\/s12951-024-02492-7.","journal-title":"Journal of Nanobiotechnology"},{"key":"4095_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125574","volume":"676","author":"G Bebawy","year":"2025","unstructured":"Bebawy G, Collier P, Williams PM, Burley JC, Needham D. Ldlr-targeted orlistat therapeutic nanoparticles: peptide selection, assembly, characterization, and cell-uptake in breast cancer cell lines. Int J Pharm. 2025;676:125574. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125574.","journal-title":"Int J Pharm"},{"key":"4095_CR221","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/nnm.15.193","volume":"11","author":"A Bhargava-Shah","year":"2016","unstructured":"Bhargava-Shah A, Foygel K, Devulapally R, Paulmurugan R. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy. Nanomedicine (Lond). 2016;11:235\u201347. https:\/\/doi.org\/10.2217\/nnm.15.193.","journal-title":"Nanomedicine (Lond)"},{"key":"4095_CR222","doi-asserted-by":"publisher","first-page":"8182","DOI":"10.1002\/jcp.27615","volume":"234","author":"MN Oskouie","year":"2019","unstructured":"Oskouie MN, Aghili Moghaddam NS, Butler AE, Zamani P, Sahebkar A. Therapeutic use of curcumin-encapsulated and curcumin-primed exosomes. J Cell Physiol. 2019;234:8182\u201391. https:\/\/doi.org\/10.1002\/jcp.27615.","journal-title":"J Cell Physiol"},{"key":"4095_CR223","doi-asserted-by":"publisher","unstructured":"\u00c1vila-G\u00e1lvez M\u00c1, Garay-Mayol B, Gim\u00e9nez-Bastida JA, Hazas M del CL de las, Mazar\u00edo-G\u00e1rgoles C, Brito MA, et al. Enhanced brain delivery and antiproliferative activity of resveratrol using milk-derived exosomes. Journal of Agriculture and Food Research. 2024;18:101370. https:\/\/doi.org\/10.1016\/j.jafr.2024.101370.","DOI":"10.1016\/j.jafr.2024.101370"},{"key":"4095_CR224","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03087-2","volume":"23","author":"N Gonzalez Suarez","year":"2023","unstructured":"Gonzalez Suarez N, Fernandez-Marrero Y, H\u00e9bert MPA, Roy M-E, Boudreau LH, Annabi B. EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells. Cancer Cell Int. 2023;23:240. https:\/\/doi.org\/10.1186\/s12935-023-03087-2.","journal-title":"Cancer Cell Int"},{"key":"4095_CR225","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.actbio.2021.03.018","volume":"126","author":"Z-S Gao","year":"2021","unstructured":"Gao Z-S, Zhang C-J, Xia N, Tian H, Li D-Y, Lin J-Q, et al. Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy. Acta Biomater. 2021;126:211\u201323. https:\/\/doi.org\/10.1016\/j.actbio.2021.03.018.","journal-title":"Acta Biomater"},{"key":"4095_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120716","volume":"271","author":"X Zheng","year":"2021","unstructured":"Zheng X, Zhao Y, Jia Y, Shao D, Zhang F, Sun M, et al. Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis. Biomaterials. 2021;271:120716. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120716.","journal-title":"Biomaterials"},{"key":"4095_CR227","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061567","volume":"15","author":"X Kang","year":"2023","unstructured":"Kang X, Jadhav S, Annaji M, Huang C-H, Amin R, Shen J, et al. Advancing Cancer Therapy with Copper\/Disulfiram Nanomedicines and Drug Delivery Systems. Pharmaceutics. 2023;15:1567. https:\/\/doi.org\/10.3390\/pharmaceutics15061567.","journal-title":"Pharmaceutics"},{"key":"4095_CR228","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12:1416. https:\/\/doi.org\/10.3390\/cells12101416.","journal-title":"Cells"},{"key":"4095_CR229","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.biopha.2018.06.159","volume":"106","author":"M Imran","year":"2018","unstructured":"Imran M, Rauf A, Khan IA, Shahbaz M, Qaisrani TB, Fatmawati S, et al. Thymoquinone: A novel strategy to combat cancer: A review. Biomedicine & Pharmacotherapy Elsevier BV. 2018;106:390\u2013402. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.159.","journal-title":"Biomedicine & Pharmacotherapy Elsevier BV"},{"key":"4095_CR230","doi-asserted-by":"publisher","unstructured":"Asaduzzaman Khan Md, Tania M, Fu S, Fu J. Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget. Impact Journals, LLC; 2017;8:51907\u201319. https:\/\/doi.org\/10.18632\/oncotarget.17206.","DOI":"10.18632\/oncotarget.17206"},{"key":"4095_CR231","doi-asserted-by":"publisher","DOI":"10.3390\/foods13172811","volume":"13","author":"JL Scott","year":"2024","unstructured":"Scott JL, Gupta RC, Aqil F, Jeyabalan J, Schultz DJ. Exosomal Delivery Enhances the Antiproliferative Effects of Acid-Hydrolyzed Apiaceae Spice Extracts in Breast Cancer Cells. Foods. 2024;13:2811. https:\/\/doi.org\/10.3390\/foods13172811.","journal-title":"Foods"},{"key":"4095_CR232","doi-asserted-by":"publisher","unstructured":"Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res. 2009;59:365\u201378. https:\/\/doi.org\/10.1016\/j.phrs.2009.01.017.","DOI":"10.1016\/j.phrs.2009.01.017"},{"key":"4095_CR233","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/s0024-3205(00)00720-7","volume":"67","author":"WK Liu","year":"2000","unstructured":"Liu WK, Xu SX, Che CT, Elsevier BV. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 2000;67:1297\u2013306. https:\/\/doi.org\/10.1016\/s0024-3205(00)00720-7.","journal-title":"Life Sci"},{"key":"4095_CR234","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.canlet.2006.01.027","volume":"245","author":"RL Thangapazham","year":"2007","unstructured":"Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK, et al. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007;245:232\u201341. https:\/\/doi.org\/10.1016\/j.canlet.2006.01.027.","journal-title":"Cancer Lett"},{"key":"4095_CR235","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D, et al. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56:836\u201349. https:\/\/doi.org\/10.1038\/s12276-024-01201-6.","journal-title":"Exp Mol Med"},{"key":"4095_CR236","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jconrel.2014.12.013","volume":"199","author":"T Smyth","year":"2015","unstructured":"Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ, et al. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015;199:145\u201355. https:\/\/doi.org\/10.1016\/j.jconrel.2014.12.013.","journal-title":"J Control Release"},{"key":"4095_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119675","volume":"231","author":"S Le Saux","year":"2020","unstructured":"Le Saux S, Aarrass H, Lai-Kee-Him J, Bron P, Armengaud J, Miotello G, et al. Post-production modifications of murine mesenchymal stem cell (mMSC) derived extracellular vesicles (EVs) and impact on their cellular interaction. Biomaterials. 2020;231:119675. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119675.","journal-title":"Biomaterials"},{"key":"4095_CR238","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.7150\/thno.30716","volume":"9","author":"P Wang","year":"2019","unstructured":"Wang P, Wang H, Huang Q, Peng C, Yao L, Chen H, et al. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation. Theranostics Ivyspring International Publisher. 2019;9:1714\u201327. https:\/\/doi.org\/10.7150\/thno.30716.","journal-title":"Theranostics Ivyspring International Publisher"},{"key":"4095_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01526-2","volume":"20","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zheng Y, Zhu Y, Li H, Zhu H, Liu T. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer. J Nanobiotechnology. 2022;20:359. https:\/\/doi.org\/10.1186\/s12951-022-01526-2.","journal-title":"J Nanobiotechnology"},{"key":"4095_CR240","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1208\/s12248-017-0154-9","volume":"19","author":"F Aqil","year":"2017","unstructured":"Aqil F, Munagala R, Jeyabalan J, Agrawal AK, Gupta R. Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. AAPS J. 2017;19:1691\u2013702. https:\/\/doi.org\/10.1208\/s12248-017-0154-9.","journal-title":"AAPS J"},{"key":"4095_CR241","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","volume":"27","author":"S Salarpour","year":"2019","unstructured":"Salarpour S, Forootanfar H, Pournamdari M, Ahmadi-Zeidabadi M, Esmaeeli M, Pardakhty A. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. Daru. 2019;27:533\u20139. https:\/\/doi.org\/10.1007\/s40199-019-00280-5.","journal-title":"Daru"},{"key":"4095_CR242","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01007-y","volume":"15","author":"T Abdul-Rahman","year":"2024","unstructured":"Abdul-Rahman T, Roy P, Herrera-Calder\u00f3n RE, Khidri FF, Omotesho QA, Rumide TS, et al. Extracellular vesicle-mediated drug delivery in breast cancer theranostics. Discov Oncol. 2024;15:181. https:\/\/doi.org\/10.1007\/s12672-024-01007-y.","journal-title":"Discov Oncol"},{"key":"4095_CR243","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. Exosomes as Drug Delivery Vehicles for Parkinson\u2019s Disease Therapy. J Control Release. 2015;207:18\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.033.","journal-title":"J Control Release"},{"key":"4095_CR244","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1039\/D4NA00501E","volume":"6","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS, Shah B, Kapre S, Charbe N, Immanuel S, Pasham S, et al. A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv. 2024;6:5803\u201326. https:\/\/doi.org\/10.1039\/D4NA00501E.","journal-title":"Nanoscale Adv"},{"key":"4095_CR245","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12195-016-0457-4","volume":"9","author":"TN Lamichhane","year":"2016","unstructured":"Lamichhane TN, Jeyaram A, Patel DB, Parajuli B, Livingston NK, Arumugasaamy N, et al. Oncogene Knockdown via Active Loading of Small RNAs into Extracellular Vesicles by Sonication. Cell Mol Bioeng. 2016;9:315\u201324. https:\/\/doi.org\/10.1007\/s12195-016-0457-4.","journal-title":"Cell Mol Bioeng"},{"key":"4095_CR246","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11481-019-09884-9","volume":"15","author":"MJ Haney","year":"2020","unstructured":"Haney MJ, Zhao Y, Jin YS, Li SM, Bago JR, Klyachko NL, et al. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. J Neuroimmune Pharmacol. 2020;15:487\u2013500. https:\/\/doi.org\/10.1007\/s11481-019-09884-9.","journal-title":"J Neuroimmune Pharmacol"},{"key":"4095_CR247","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","volume":"14","author":"MS Kim","year":"2018","unstructured":"Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, et al. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomedicine. 2018;14:195\u2013204. https:\/\/doi.org\/10.1016\/j.nano.2017.09.011.","journal-title":"Nanomedicine"},{"key":"4095_CR248","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1111\/cas.14181","volume":"110","author":"M Yu","year":"2019","unstructured":"Yu M, Gai C, Li Z, Ding D, Zheng J, Zhang W, et al. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Sci. 2019;110:3173\u201382. https:\/\/doi.org\/10.1111\/cas.14181.","journal-title":"Cancer Sci"},{"key":"4095_CR249","doi-asserted-by":"publisher","unstructured":"Uslu D, Abas B, Demi\u0307rbolat G, Cevik O. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells. Mol Diversity [Internet]. 2024 [cited 2025 Oct 17];28. https:\/\/doi.org\/10.1007\/s11030-022-10591-6.","DOI":"10.1007\/s11030-022-10591-6"},{"key":"4095_CR250","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.canlet.2019.02.011","volume":"449","author":"F Aqil","year":"2019","unstructured":"Aqil F, Munagala R, Jeyabalan J, Agrawal AK, Kyakulaga A-H, Wilcher SA, et al. Milk exosomes - Natural nanoparticles for siRNA delivery. Cancer Lett. 2019;449:186\u201395. https:\/\/doi.org\/10.1016\/j.canlet.2019.02.011.","journal-title":"Cancer Lett"},{"key":"4095_CR251","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtm.2019.01.001","volume":"13","author":"MAC Pomatto","year":"2019","unstructured":"Pomatto MAC, Bussolati B, D\u2019Antico S, Ghiotto S, Tetta C, Brizzi MF, et al. Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs. Mol Ther Methods Clin Dev. 2019;13:133\u201344. https:\/\/doi.org\/10.1016\/j.omtm.2019.01.001.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4095_CR252","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.2147\/IJN.S131786","volume":"12","author":"WJ Goh","year":"2017","unstructured":"Goh WJ, Lee CK, Zou S, Woon EC, Czarny B, Pastorin G. Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy. Int J Nanomedicine. 2017;12:2759\u201367. https:\/\/doi.org\/10.2147\/IJN.S131786.","journal-title":"Int J Nanomedicine"},{"key":"4095_CR253","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23102564","volume":"23","author":"T Wang","year":"2018","unstructured":"Wang T, Larcher LM, Ma L, Veedu RN. Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides. Molecules. 2018;23:2564. https:\/\/doi.org\/10.3390\/molecules23102564.","journal-title":"Molecules"},{"key":"4095_CR254","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1208\/s12248-016-0015-y","volume":"19","author":"T Yang","year":"2017","unstructured":"Yang T, Fogarty B, LaForge B, Aziz S, Pham T, Lai L, et al. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer. AAPS J. 2017;19:475\u201386. https:\/\/doi.org\/10.1208\/s12248-016-0015-y.","journal-title":"AAPS J"},{"key":"4095_CR255","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11101-010-9183-z","volume":"9","author":"I Podolak","year":"2010","unstructured":"Podolak I, Galanty A, Sobolewska D. Saponins as cytotoxic agents: a review. Phytochem Rev. 2010;9:425\u201374. https:\/\/doi.org\/10.1007\/s11101-010-9183-z.","journal-title":"Phytochem Rev"},{"key":"4095_CR256","doi-asserted-by":"publisher","unstructured":"Gharavi AT, Irian S, Niknejad A, Parang K, Salimi M. Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for in vivo and in vitro studies. Molecular Therapy Oncology [Internet]. Elsevier; 2024 [cited 2025 Oct 17];32. https:\/\/doi.org\/10.1016\/j.omton.2024.200800.","DOI":"10.1016\/j.omton.2024.200800"},{"issue":"1","key":"4095_CR257","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","volume":"10","author":"G Xu","year":"2025","unstructured":"Xu G, Jin J, Fu Z, Wang G, Lei X, Xu J, et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Target Ther. 2025;10:255. https:\/\/doi.org\/10.1038\/s41392-025-02312-w.","journal-title":"Signal Transduct Target Ther"},{"key":"4095_CR258","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020473","volume":"12","author":"YJ Jang","year":"2023","unstructured":"Jang YJ, Cha BS, Kim D, Lee ES, Kim S, Han J, et al. Extracellular Vesicles, as Drug-Delivery Vehicles, Improve the Biological Activities of Astaxanthin. Antioxidants (Basel). 2023;12:473. https:\/\/doi.org\/10.3390\/antiox12020473.","journal-title":"Antioxidants (Basel)"},{"key":"4095_CR259","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051426","volume":"15","author":"S Ashique","year":"2023","unstructured":"Ashique S, Anand K. Radiolabelled extracellular vesicles as imaging modalities for precise targeted drug delivery. Pharmaceutics. 2023;15:1426. https:\/\/doi.org\/10.3390\/pharmaceutics15051426.","journal-title":"Pharmaceutics"},{"key":"4095_CR260","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2147\/ijn.s191313","volume":"14","author":"R Kanchanapally","year":"2019","unstructured":"Kanchanapally R, Deshmukh SK, Chavva SR, Tyagi N, Srivastava SK, Patel GK, et al. Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. Int J Nanomedicine. 2019;14:531\u201341. https:\/\/doi.org\/10.2147\/ijn.s191313.","journal-title":"Int J Nanomedicine"},{"key":"4095_CR261","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","volume":"371","author":"R Munagala","year":"2016","unstructured":"Munagala R, Aqil F, Jeyabalan J, Gupta RC, Elsevier BV. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016;371:48\u201361. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.020.","journal-title":"Cancer Lett"},{"key":"4095_CR262","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","volume":"220","author":"H Saari","year":"2015","unstructured":"Saari H, L\u00e1zaro-Ib\u00e1\u00f1ez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M, et al. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells. J Control Release. 2015;220:727\u201337. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.031.","journal-title":"J Control Release"},{"key":"4095_CR263","doi-asserted-by":"publisher","unstructured":"Schindler C, Collinson A, Matthews C, Pointon A, Jenkinson L, Minter RR, et al. Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency. PLOS ONE. Public Libr Sci. (PLoS); 2019;14:e0214545. https:\/\/doi.org\/10.1371\/journal.pone.0214545.","DOI":"10.1371\/journal.pone.0214545"},{"key":"4095_CR264","doi-asserted-by":"publisher","unstructured":"Sancho-Albero M, Encabo-Berzosa M, Beltr\u00e1n-Visiedo M, Fern\u00e1ndez-Messina L, Sebasti\u00e1n V, S\u00e1nchez-Madrid F, et al. Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids. Nanoscale. 2019;11:18825\u201336. https:\/\/doi.org\/10.1039\/c9nr06183e.","DOI":"10.1039\/c9nr06183e"},{"key":"4095_CR265","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2014.11.029","volume":"205","author":"G Fuhrmann","year":"2015","unstructured":"Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM, Elsevier BV. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release. 2015;205:35\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.029.","journal-title":"J Control Release"},{"key":"4095_CR266","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12163","volume":"10","author":"C Chen","year":"2021","unstructured":"Chen C, Sun M, Wang J, Su L, Lin J, Yan X. Active cargo loading into extracellular vesicles: highlights the heterogeneous encapsulation behaviour. J Extracell Vesicles. 2021;10:e12163. https:\/\/doi.org\/10.1002\/jev2.12163.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR267","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010038","author":"AJ Lenna\u00e1rd","year":"2021","unstructured":"Lenna\u00e1rd AJ, Mamand DR, Wiklander RJ, Andaloussi SE, Wiklander OPB, Multidisciplinary Digital Publishing Institute. Optimised electroporation for loading of extracellular vesicles with doxorubicin. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics14010038.","journal-title":"Pharmaceutics"},{"key":"4095_CR268","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41551-019-0502-4","volume":"4","author":"R Reshke","year":"2020","unstructured":"Reshke R, Taylor JA, Savard A, Guo H, Rhym LH, Kowalski PS, et al. Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone. Nat Biomed Eng. 2020;4:52\u201368. https:\/\/doi.org\/10.1038\/s41551-019-0502-4.","journal-title":"Nat Biomed Eng"},{"key":"4095_CR269","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","volume":"317","author":"G Kim","year":"2020","unstructured":"Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release. 2020;317:273\u201381. https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.009.","journal-title":"J Control Release"},{"key":"4095_CR270","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","volume":"4","author":"Z Yang","year":"2020","unstructured":"Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020;4:69\u201383. https:\/\/doi.org\/10.1038\/s41551-019-0485-1.","journal-title":"Nat Biomed Eng"},{"key":"4095_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2024.102096","volume":"32","author":"R Gul","year":"2024","unstructured":"Gul R, Bashir H, Sarfraz M, Shaikh AJ, Bin Jardan YA, Hussain Z, et al. Human plasma derived exosomes: Impact of active and passive drug loading approaches on drug delivery. Saudi Pharmaceutical Journal. 2024;32:102096. https:\/\/doi.org\/10.1016\/j.jsps.2024.102096.","journal-title":"Saudi Pharmaceutical Journal"},{"key":"4095_CR272","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.2147\/IJN.S263956","volume":"15","author":"A Thakur","year":"2020","unstructured":"Thakur A, Sidu RK, Zou H, Alam MK, Yang M, Lee Y. Inhibition of Glioma Cells\u2019 Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics. Int J Nanomedicine. 2020;15:8331\u201343. https:\/\/doi.org\/10.2147\/IJN.S263956.","journal-title":"Int J Nanomedicine"},{"key":"4095_CR273","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.939441","volume":"10","author":"A Liu","year":"2022","unstructured":"Liu A, Yang G, Liu Y, Liu T. Research progress in membrane fusion-based hybrid exosomes for drug delivery systems. Front Bioeng Biotechnol. 2022;10:939441. https:\/\/doi.org\/10.3389\/fbioe.2022.939441.","journal-title":"Front Bioeng Biotechnol"},{"key":"4095_CR274","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118813","volume":"193","author":"M Guarro","year":"2025","unstructured":"Guarro M, van Veen S, Borr\u00f3s S, Albertazzi L, Lecina M, Fornaguera C. Quantitative and qualitative comparison of mRNA loading techniques into extracellular vesicles. Biomed Pharmacother. 2025;193:118813. https:\/\/doi.org\/10.1016\/j.biopha.2025.118813.","journal-title":"Biomed Pharmacother"},{"key":"4095_CR275","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13036-023-00353-9","volume":"17","author":"SA Bernal-Ch\u00e1vez","year":"2023","unstructured":"Bernal-Ch\u00e1vez SA, Romero-Montero A, Hern\u00e1ndez-Parra H, Pe\u00f1a-Corona SI, Del Prado-Audelo ML, Alcal\u00e1-Alcal\u00e1 S, et al. Enhancing chemical and physical stability of pharmaceuticals using freeze-thaw method: challenges and opportunities for process optimization through quality by design approach. J Biol Eng. 2023;17:35. https:\/\/doi.org\/10.1186\/s13036-023-00353-9.","journal-title":"J Biol Eng"},{"key":"4095_CR276","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02259-6","volume":"22","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xiong M, Tian J, Song D, Duan S, Zhang L. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. J Nanobiotechnol. 2024;22:18. https:\/\/doi.org\/10.1186\/s12951-023-02259-6.","journal-title":"J Nanobiotechnol"},{"key":"4095_CR277","doi-asserted-by":"publisher","first-page":"21933","DOI":"10.1038\/srep21933","volume":"6","author":"YT Sato","year":"2016","unstructured":"Sato YT, Umezaki K, Sawada S, Mukai S, Sasaki Y, Harada N, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6:21933. https:\/\/doi.org\/10.1038\/srep21933.","journal-title":"Sci Rep"},{"key":"4095_CR278","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-024-04022-8","volume":"19","author":"S Zuppone","year":"2024","unstructured":"Zuppone S, Zarovni N, Noguchi K, Loria F, Morasso C, L\u00f5hmus A, et al. Novel loading protocol combines highly efficient encapsulation of exogenous therapeutic toxin with preservation of extracellular vesicles properties, uptake and cargo activity. Discov Nano. 2024;19:76. https:\/\/doi.org\/10.1186\/s11671-024-04022-8.","journal-title":"Discov Nano"},{"key":"4095_CR279","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1039\/D4LC01103A","volume":"25","author":"C Piunti","year":"2025","unstructured":"Piunti C, Micheli S, Giancaterino S, Fusco P, Boi C, Cimetta E, et al. Microfluidic loading of verteporfin into extracellular vesicles for neuroblastoma therapy. Lab Chip. 2025;25:1718\u201327. https:\/\/doi.org\/10.1039\/D4LC01103A.","journal-title":"Lab Chip"},{"key":"4095_CR280","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.160915","volume":"512","author":"N Mukerjee","year":"2025","unstructured":"Mukerjee N, Maitra S, Kaur M, Rekha MM, Soothwal P, Arora I, et al. Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics. Chem Eng J. 2025;512:160915. https:\/\/doi.org\/10.1016\/j.cej.2025.160915.","journal-title":"Chem Eng J"},{"key":"4095_CR281","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/1535-7163.MCT-20-0484","volume":"20","author":"ND Lewis","year":"2021","unstructured":"Lewis ND, Sia CL, Kirwin K, Haupt S, Mahimkar G, Zi T, et al. Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12. Mol Cancer Ther. 2021;20:523\u201334. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0484.","journal-title":"Mol Cancer Ther"},{"key":"4095_CR282","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ymthe.2021.01.020","volume":"29","author":"K Dooley","year":"2021","unstructured":"Dooley K, McConnell RE, Xu K, Lewis ND, Haupt S, Youniss MR, et al. A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Mol Ther. 2021;29:1729\u201343. https:\/\/doi.org\/10.1016\/j.ymthe.2021.01.020.","journal-title":"Mol Ther"},{"key":"4095_CR283","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2217\/nnm-2022-0328","volume":"18","author":"NH Tran","year":"2023","unstructured":"Tran NH, Nguyen DD, Nguyen NM, Tran C, Nguyen Thi NT, Ho DT, et al. Dual-targeting exosomes for improved drug delivery in breast cancer. Nanomedicine (Lond). 2023;18:599\u2013611. https:\/\/doi.org\/10.2217\/nnm-2022-0328.","journal-title":"Nanomedicine (Lond)"},{"key":"4095_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105028","volume":"89","author":"M Saha","year":"2023","unstructured":"Saha M, Ghosh SS. Targeting tumor microenvironment of metastatic triple negative breast cancer cells via exosomes derived from non-invasive breast cancer cells for multi-drug resistance inhibition and enhancing drug susceptibility. J Drug Deliv Sci Technol. 2023;89:105028. https:\/\/doi.org\/10.1016\/j.jddst.2023.105028.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4095_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2025.113633","volume":"251","author":"J Hu","year":"2025","unstructured":"Hu J, Yang S, Zhu J, Chai J, Luan J, Wang Y. An engineered-exosome disguised multifunctional nanoplatform for enhanced chemo-photothermal therapy of triple-negative breast cancer. Mater Des. 2025;251:113633. https:\/\/doi.org\/10.1016\/j.matdes.2025.113633.","journal-title":"Mater Des"},{"key":"4095_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125907","volume":"682","author":"N Verma","year":"2025","unstructured":"Verma N, Tamang R, Mehata AK, Setia A, Koch B, Muthu MS. Exosomes fused liposomes: formulation, stability studies and theranostic evaluation for breast cancer applications. Int J Pharm. 2025;682:125907. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125907.","journal-title":"Int J Pharm"},{"key":"4095_CR287","doi-asserted-by":"publisher","unstructured":"Xu M, Bai L, Sun M, Yan X, Xiong Y, Wang Y, et al. ROS-responsive biomimetic nanocomplexes of liposomes and macrophage-derived exosomes for combination breast cancer therapy. Int J Nanomedicine. 2025;Volume 20:5161\u201380. https:\/\/doi.org\/10.2147\/ijn.s514375.","DOI":"10.2147\/ijn.s514375"},{"key":"4095_CR288","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.7150\/thno.65516","volume":"12","author":"TG Nguyen Cao","year":"2022","unstructured":"Nguyen Cao TG, Kang JH, Kim W, Lim J, Kang SJ, You JY, et al. Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy. Theranostics Ivyspring International Publisher. 2022;12:1247\u201366. https:\/\/doi.org\/10.7150\/thno.65516.","journal-title":"Theranostics Ivyspring International Publisher"},{"key":"4095_CR289","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020451","volume":"14","author":"F St-Denis-Bissonnette","year":"2022","unstructured":"St-Denis-Bissonnette F, Khoury R, Mediratta K, El-Sahli S, Wang L, Lavoie JR, et al. Applications of extracellular vesicles in triple-negative breast cancer. Cancers. 2022;14:451. https:\/\/doi.org\/10.3390\/cancers14020451.","journal-title":"Cancers"},{"key":"4095_CR290","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.822805","volume":"12","author":"Q Liu","year":"2022","unstructured":"Liu Q, Dai G, Wu Y, Zhang M, Yang M, Wang X, et al. iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma. Front Oncol. 2022;12:822805. https:\/\/doi.org\/10.3389\/fonc.2022.822805.","journal-title":"Front Oncol"},{"key":"4095_CR291","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097580","volume":"9","author":"S Dutta","year":"2014","unstructured":"Dutta S, Warshall C, Bandyopadhyay C, Dutta D, Chandran B, Public Library of Science (PLoS). Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS One. 2014;9:e97580. https:\/\/doi.org\/10.1371\/journal.pone.0097580.","journal-title":"PLoS One"},{"key":"4095_CR292","doi-asserted-by":"publisher","DOI":"10.3390\/polym13152529","volume":"13","author":"M Shafiei","year":"2021","unstructured":"Shafiei M, Ansari MNM, Razak SIA, Khan MUA, MDPI AG. A comprehensive review on the applications of exosomes and liposomes in regenerative medicine and tissue engineering. Polymers. 2021;13:2529. https:\/\/doi.org\/10.3390\/polym13152529.","journal-title":"Polymers"},{"key":"4095_CR293","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82291-0","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ji Q, Yan C, Ji P, Nature Publishing Group. Biomimetic intelligent nanoplatform with cascade amplification effect for tumor synergy therapy. Sci Rep. 2024;14:31067. https:\/\/doi.org\/10.1038\/s41598-024-82291-0.","journal-title":"Sci Rep"},{"key":"4095_CR294","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw W-S, Chen C-A, Zhou QA, et al. Exosomes\u2500nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16:17802\u201346. https:\/\/doi.org\/10.1021\/acsnano.2c08774.","journal-title":"ACS Nano"},{"key":"4095_CR295","doi-asserted-by":"publisher","unstructured":"Abdel-Bar HM, Tandiono S, Liam-Or R, Cheung CCL, Hassuneh OWM, Lyu Q, et al. Optimizing exosome lipid hybrid nanoparticles for enhanced siRNA delivery and improved therapeutic anticancer efficacy in vivo. ACS Nano. 2025;19:42658\u201374. https:\/\/doi.org\/10.1021\/acsnano.5c16991.","DOI":"10.1021\/acsnano.5c16991"},{"key":"4095_CR296","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59489-5","volume":"16","author":"G Son","year":"2025","unstructured":"Son G, Song J, Park JC, Kim HN, Kim H. Fusogenic lipid nanoparticles for rapid delivery of large therapeutic molecules to exosomes. Nat Commun. 2025;16:4799. https:\/\/doi.org\/10.1038\/s41467-025-59489-5.","journal-title":"Nat Commun"},{"key":"4095_CR297","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70201","volume":"14","author":"X Wang","year":"2025","unstructured":"Wang X, Munson MJ, Friis K, Marzeda A, Silva AM, Kohl F, et al. Hybrid extracellular vesicles for efficient loading and functional delivery of mRNA. J Extracell Vesicles. 2025;14:e70201. https:\/\/doi.org\/10.1002\/jev2.70201.","journal-title":"J Extracell Vesicles"},{"key":"4095_CR298","doi-asserted-by":"publisher","unstructured":"Sun W, Huang S, Sun Z, Zhao Q, Li J, Wen B, et al. Exosome platform with three-in-one functionality of mRNA therapy, immune checkpoint blockade, and mild photothermal therapy for the treatment of triple-negative breast cancer. ACS Appl Mater Interfaces. 2025;17:10328\u201341. https:\/\/doi.org\/10.1021\/acsami.4c17804.","DOI":"10.1021\/acsami.4c17804"},{"key":"4095_CR299","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00009","volume":"5","author":"IB Hench","year":"2018","unstructured":"Hench IB, Hench J, Tolnay M. Liquid biopsy in clinical management of breast, lung, and colorectal cancer. Front Med (Lausanne). 2018;5:9. https:\/\/doi.org\/10.3389\/fmed.2018.00009.","journal-title":"Front Med (Lausanne)"},{"key":"4095_CR300","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087208","volume":"24","author":"S Loric","year":"2023","unstructured":"Loric S, Denis JA, Desbene C, Sabbah M, Conti M. Extracellular vesicles in breast cancer: from biology and function to clinical diagnosis and therapeutic management. Int J Mol Sci. 2023;24:7208. https:\/\/doi.org\/10.3390\/ijms24087208.","journal-title":"Int J Mol Sci"},{"key":"4095_CR301","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030538","volume":"18","author":"H Rashed","year":"2017","unstructured":"Rashed H, Bayraktar E, Helal K, Abd-Ellah MF, Amero P, Chavez-Reyes A, et al. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci. 2017;18:538. https:\/\/doi.org\/10.3390\/ijms18030538.","journal-title":"Int J Mol Sci"},{"key":"4095_CR302","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210267","volume":"24","author":"M Nowak","year":"2023","unstructured":"Nowak M, G\u00f3rczy\u0144ska J, Ko\u0142odzi\u0144ska K, Rubin J, Choroma\u0144ska A. Extracellular vesicles as drug transporters. Int J Mol Sci. 2023;24:10267. https:\/\/doi.org\/10.3390\/ijms241210267.","journal-title":"Int J Mol Sci"},{"key":"4095_CR303","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/prca.201400114","volume":"9","author":"S Boukouris","year":"2015","unstructured":"Boukouris S, Mathivanan S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl. 2015;9:358\u201367. https:\/\/doi.org\/10.1002\/prca.201400114.","journal-title":"Proteomics Clin Appl"},{"key":"4095_CR304","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jprot.2015.10.005","volume":"131","author":"J-E Lee","year":"2016","unstructured":"Lee J-E, Moon P-G, Cho Y-E, Kim Y-B, Kim I-S, Park H, et al. Identification of EDIL3 on extracellular vesicles involved in breast cancer cell invasion. J Proteomics. 2016;131:17\u201328. https:\/\/doi.org\/10.1016\/j.jprot.2015.10.005.","journal-title":"J Proteomics"},{"key":"4095_CR305","doi-asserted-by":"publisher","first-page":"40189","DOI":"10.18632\/oncotarget.9561","volume":"7","author":"P-G Moon","year":"2016","unstructured":"Moon P-G, Lee J-E, Cho Y-E, Lee SJ, Chae YS, Jung JH, et al. Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer. Oncotarget. 2016;7:40189\u201399. https:\/\/doi.org\/10.18632\/oncotarget.9561.","journal-title":"Oncotarget"},{"key":"4095_CR306","doi-asserted-by":"publisher","DOI":"10.3390\/biom10050676","volume":"10","author":"RA Acu\u00f1a","year":"2020","unstructured":"Acu\u00f1a RA, Varas-Godoy M, Berthoud VM, Alfaro IE, Retamal MA. Connexin-46 contained in extracellular vesicles enhance malignancy features in breast cancer cells. Biomolecules. 2020;10:676. https:\/\/doi.org\/10.3390\/biom10050676.","journal-title":"Biomolecules"},{"key":"4095_CR307","doi-asserted-by":"publisher","first-page":"15137","DOI":"10.1039\/C6NR03478K","volume":"8","author":"H Etayash","year":"2016","unstructured":"Etayash H, McGee AR, Kaur K, Thundat T, The Royal Society of Chemistry. Nanomechanical sandwich assay for multiple cancer biomarkers in breast cancer cell-derived exosomes. Nanoscale. 2016;8:15137\u201341. https:\/\/doi.org\/10.1039\/C6NR03478K.","journal-title":"Nanoscale"},{"key":"4095_CR308","doi-asserted-by":"publisher","DOI":"10.1038\/srep36502","volume":"6","author":"G Kibria","year":"2016","unstructured":"Kibria G, Ramos EK, Lee KE, Bedoyan S, Huang S, Samaeekia R, et al. A rapid, automated surface protein profiling of single circulating exosomes in human blood. Sci Rep. 2016;6:36502. https:\/\/doi.org\/10.1038\/srep36502.","journal-title":"Sci Rep"},{"key":"4095_CR309","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03689-y","volume":"25","author":"FA Attar","year":"2025","unstructured":"Attar FA, Irani S, Oloomi M, Bolhassani A, Geranpayeh L, Atyabi F. Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: in vitro and in vivo study. Cancer Cell Int. 2025;25:72. https:\/\/doi.org\/10.1186\/s12935-025-03689-y.","journal-title":"Cancer Cell Int"},{"key":"4095_CR310","doi-asserted-by":"publisher","DOI":"10.3390\/life12081143","volume":"12","author":"DN Kumar","year":"2022","unstructured":"Kumar DN, Chaudhuri A, Dehari D, Shekher A, Gupta SC, Majumdar S, et al. Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer. Life (Basel). 2022;12:1143. https:\/\/doi.org\/10.3390\/life12081143.","journal-title":"Life (Basel)"},{"key":"4095_CR311","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073645","volume":"25","author":"X Wang","year":"2024","unstructured":"Wang X, Li D, Li G, Chen J, Yang Y, Bian L, et al. Enhanced therapeutic potential of hybrid exosomes loaded with paclitaxel for cancer therapy. Int J Mol Sci. 2024;25:3645. https:\/\/doi.org\/10.3390\/ijms25073645.","journal-title":"Int J Mol Sci"},{"key":"4095_CR312","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213643","volume":"154","author":"D Ferreira","year":"2023","unstructured":"Ferreira D, Santos-Pereira C, Costa M, Afonso J, Yang S, Hensel J, et al. Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomaterials Advances. 2023;154:213643. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213643.","journal-title":"Biomaterials Advances"},{"key":"4095_CR313","doi-asserted-by":"publisher","unstructured":"Mohan S, Khamjan NA, Abdelwahab SI, Taha MME, Moshi JM, Alshahrani AF, et al. Clinical frontiers of exosome research: a comprehensive analysis of human trials in diagnostics, therapeutics, and regenerative medicine. J Pharmacol Pharmacother. 2025(2). https:\/\/doi.org\/10.1177\/0976500X251361201.","DOI":"10.1177\/0976500X251361201"},{"key":"4095_CR314","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13058-019-1109-0","volume":"21","author":"A Rodr\u00edguez-Mart\u00ednez","year":"2019","unstructured":"Rodr\u00edguez-Mart\u00ednez A, de Miguel-P\u00e9rez D, Ortega FG, Garc\u00eda-Puche JL, Robles-Fern\u00e1ndez I, Exposito J, et al. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Breast Cancer Res. 2019;21:21. https:\/\/doi.org\/10.1186\/s13058-019-1109-0.","journal-title":"Breast Cancer Res"},{"key":"4095_CR315","doi-asserted-by":"publisher","unstructured":"Weitsman G, Barber PR, Nguyen LK, Lawler K, Patel G, Woodman N, et al. HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status. Oncotarget. 2016;7:51012\u201326. https:\/\/doi.org\/10.18632\/oncotarget.9963.","DOI":"10.18632\/oncotarget.9963"},{"key":"4095_CR316","doi-asserted-by":"publisher","unstructured":"Tripathy A, Corkos P, Blouw B, Montgomery DA, Moore M, Hedrick MH, et al. Longitudinal CSF tumor cell enumeration and mutational analysis as a driver for leptomeningeal disease management. Cancers. 2025;17:825. https:\/\/doi.org\/10.3390\/cancers17050825.","DOI":"10.3390\/cancers17050825"},{"key":"4095_CR317","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03887-5","volume":"23","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zhang Q, Chen H, Liu S, Peng K, Wang X, et al. Multi-cancer early detection based on serum surface-enhanced Raman spectroscopy with deep learning: a large-scale case\u2013control study. BMC Med. 2025;23:97. https:\/\/doi.org\/10.1186\/s12916-025-03887-5.","journal-title":"BMC Med"},{"key":"4095_CR318","unstructured":"Eubanks SE. A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [Internet]. clinicaltrials.gov; 2017 July. Report No.: NCT01344109. https:\/\/clinicaltrials.gov\/study\/NCT01344109. Accessed 30 Oct 2025"},{"key":"4095_CR319","unstructured":"JI-YEON. Development of a Prognostic and Predictive Biomarker for Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy Using Exosome [Internet]. clinicaltrials.gov; 2023 July. Report No.: NCT05955521. https:\/\/clinicaltrials.gov\/study\/NCT05955521. Accessed 30 Oct 2025"},{"key":"4095_CR320","unstructured":"Centre Oscar Lambret. Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis From Breast Cancer [Internet]. clinicaltrials.gov; 2025 Sept. Report No.: NCT05286684. https:\/\/clinicaltrials.gov\/study\/NCT05286684. Accessed 30 Oct 2025"},{"key":"4095_CR321","unstructured":"Centre Oscar Lambret. Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer (OMERIC): A Cohort Study [Internet]. clinicaltrials.gov; 2024 Dec. Report No.: NCT04653740. https:\/\/clinicaltrials.gov\/study\/NCT04653740. Accessed 30 Oct 2025"},{"key":"4095_CR322","unstructured":"Poitiers University Hospital. Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer [Internet]. clinicaltrials.gov; 2024 Feb. Report No.: NCT04530890. https:\/\/clinicaltrials.gov\/study\/NCT04530890. Accessed 30 Oct 2025"},{"key":"4095_CR323","unstructured":"Centre Oscar Lambret. Benefit of Analyzing Exosomes in the Cerebrospinal Fluid During the Medical Care of Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis. [Internet]. clinicaltrials.gov; 2025 Sept. Report No.: NCT03974204. https:\/\/clinicaltrials.gov\/study\/NCT03974204. Accessed 30 Oct 2025"},{"key":"4095_CR324","unstructured":"Connolly E. Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer With and Without Intra-operative RT: a Window of Opportunity Study [Internet]. clinicaltrials.gov; 2024 June. Report No.: NCT02977468. https:\/\/clinicaltrials.gov\/study\/NCT02977468. Accessed 30 Oct 2025"},{"key":"4095_CR325","unstructured":"Im Y-H. Genetic Characteristics of Metastatic Breast Cancer Patients [Internet]. clinicaltrials.gov; 2020 Feb. Report No.: NCT04258735. https:\/\/clinicaltrials.gov\/study\/NCT04258735. Accessed 30 Oct 2025"},{"key":"4095_CR326","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo J-K, Choi C. Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regen Med. 2021;18:499\u2013511. https:\/\/doi.org\/10.1007\/s13770-021-00361-0.","journal-title":"Tissue Eng Regen Med"},{"key":"4095_CR327","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040822","volume":"13","author":"A Nicolini","year":"2021","unstructured":"Nicolini A, Ferrari P, Biava PM. Exosomes and cell communication: from tumour-derived exosomes and their role in tumour progression to the use of exosomal cargo for cancer treatment. Cancers (Basel). 2021;13:822. https:\/\/doi.org\/10.3390\/cancers13040822.","journal-title":"Cancers (Basel)"},{"key":"4095_CR328","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147794","volume":"25","author":"KWA Lee","year":"2024","unstructured":"Lee KWA, Chan LKW, Hung LC, Phoebe LKW, Park Y, Yi K-H. Clinical Applications of Exosomes: A Critical Review. Int J Mol Sci. 2024;25:7794. https:\/\/doi.org\/10.3390\/ijms25147794.","journal-title":"Int J Mol Sci"},{"key":"4095_CR329","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16111394","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lan M, Chen Y. Minimal information for studies of extracellular vesicles (MISEV): ten-year evolution (2014\u20132023). Pharmaceutics. 2024;16:1394. https:\/\/doi.org\/10.3390\/pharmaceutics16111394.","journal-title":"Pharmaceutics"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04095-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:44:50Z","timestamp":1783629890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04095-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":329,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4095"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04095-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (review article).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval."}},{"value":"The authors report there are no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}